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ABSTRACT OF THE DISSERTATION 
SCREENING OF PLANTS FOR ANTIBACTERIAL PROPERTIES:  GROWTH 
INHIBITION OF STAPHYLOCOCCUS AUREUS BY ARTEMISIA TRIDENTATA 
by 
Steven Eichelbaum 
Florida International University, 2017 
Miami, Florida 
Professor Alejandro Barbieri, Major Professor 
 Drug-resistant pathogenic and opportunistic bacteria are increasing in occurrence 
and prevalence, and pose a dangerous threat to human health.  In the search for novel 
antibiotics with which to combat this threat, plants, specifically those used in traditional 
medicine with ascribed antibacterial properties, offer a promising and potentially vast 
source of such therapeutic compounds.  The purpose of this study was therefore to screen 
chemical extracts created from various plant species for antibacterial properties versus 
pathogenic bacterial species.  In the course of these antibacterial assays, we successfully 
identified a methanol extract derived from Artemisia tridentata tridentata plant material 
as capable of inhibiting the growth of the opportunistic pathogen Staphylococcus aureus.  
Three sub-fractions were created using hexane, ethyl acetate and water solvents.  Each of 
these extracts displayed significant antibacterial activity versus a wild-type strain over a 
period of six hours, at concentrations as low as 62.5 µg/ml.  The extracts also 
demonstrated an enhancement of antibiotic effects when combined with ampicillin, G418 
sulfate or amikacin, for a period of up to twelve hours.  Though the efficacy of the 
extracts was lessened when tested against an ampicillin-resistant strain, significant 
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enhancement of the efficacy of this antibiotic was still observed.  Gas chromatography-
mass spectrometry analysis of these three extracts revealed the sesquiterpene lactone 
achillin as present in each.  Column chromatography of the hexane extract resulted in a 
fraction retaining its antibacterial activity, and still containing this compound, further 
implicating it as responsible for the antibacterial activity of this plant.  The results of 
serial dilution and plating of extract-treated samples, along with those of ethidium 
bromide assays and transmission electron microscopy analysis, indicated a bacteriostatic 
mechanism of action involving disruption of the bacterial membrane, which is in 
agreement with the literature on the antibacterial properties of this plant, and those of 
sesquiterpene lactones, respectively. We therefore conclude that achillin, likely produced 
as a secondary metabolite by Artemisia tridentata tridentata, possesses growth inhibitory 
properties versus Staphylococcus aureus, and should be isolated and studied further for 
the purposes of evaluating its potential use, either as a stand-alone antibiotic, or as an 
adjunctive therapeutic, in the treatment of drug-resistant bacterial pathogens. 
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I.  INTRODUCTION 
 Antibiotic-resistant bacteria pose a global health threat.  Infectious diseases, 
increasingly resulting from antibiotic-resistant pathogenic or opportunistic bacteria, 
represent the leading annual cause of human fatalities
1
.  These deaths include a 
staggering ½ of all fatalities in tropical countries, with gastrointestinal infections alone, 
for example, claiming the lives up to 3 million pre-school aged children per year
2
.  In 
addition, infectious diseases have also arisen as a significant source of morbidity and/or 
mortality in immunocompromised patients, in both developing and developed 
countries
3,4
.  In HIV cases for example, opportunistic infections represent the leading 
cause of death in AIDS patients
5
, with bacterial complications both facilitating the 
infection rate of the HIV virus and reducing the onset time of this disease
2
. Further, there 
has been an alarming increase in the occurrence of new diseases, and a re-emergence of 
old ones, accompanied by an increasing prevalence of resistance to antibiotics in clinical 
use
6
.  In fact, despite the availability of more than 200 varieties of antibiotics and 
chemotherapeutics, the occurrence of multi-drug resistant bacteria is at its peak
7
.  The 
seriousness of the threat posed by antibiotic-resistant bacteria is thus underscored both by 
its current impact, and the potential ramifications of its increasing prevalence.     
 The recent reporting of increases in both the number and prevalence of 
staphylococcal infections, such as those of methicillin-resistant Staphylococcus aureus, 
combined with the emergence of vancomycin-resistant isolates
8
, serves as evidence of the 
current impact of antibiotic resistance on human disease.  In fact, the level of resistance 
in clinical isolates of Staphylococcus pneumoniae to antibiotics routinely used for such 
infections has been reported to be as high as 40% in some parts of Europe
8
.  Therapeutic 
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options for methicillin-resistant Staphylococcus aureus (MRSA) have become limited as 
well, as strains resistant to synthetic antibiotics including macrolides, aminoglycosides, 
fluroquinolones, chloramphenicol, clindamycin, tetracycline, vancomycin, oxazolidine-
type and streptogramin-type antibiotics, in addition to β-lactams, have emerged9,10.  It is 
also worth noting that the increase in the occurrence of drug-resistance has been mirrored 
by a significant reduction in the number of pharmaceutical companies developing new 
antimicrobial agents
11
.     
However, antibiotic resistant bacteria also have a significant negative impact on 
agriculture.  In fish aquaculture for example, the fast development of the industry, 
combined with increasing product demands, can lead to overcrowding, poor water 
quality, or poor nutritional status, which can contribute to stress and immunosuppression 
in the fish, increasing the risk of disease dissemination
12
.  This infection risk necessitates 
the administration of antimicrobials and other veterinary drugs, which are also used for 
growth promotion, for prophylactic and therapeutic purposes
12
, all of which are practices 
which can unfortunately select for antibiotic-resistance.  As an example of drug-
resistance in agricultural animals, chicken and pork have become vehicles for livestock-
associated MRSA strains, adding an epidemiological dimension to the pathogen in the 
food supply
13
.   
Alternatively, in crop farming, biocide use at sub-lethal concentrations, in some 
cases due to limited availability
14
, while in others possibly the result of legal impositions 
on the application of synthetic antibiotics to crops, hampers disease control, and is 
another practice which may select for antibiotic resistance
15
.  In Europe for example, the 
protocol of EUREPGAP (European Good Agricultural Practice) places restrictions on the 
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allowable residue limits of pesticides on fruits and vegetables
16
, and the use of antibiotic 
and copper compounds is restricted in many countries over concerns pertaining to human 
and animal health or the environment
14
.  Arguably as a direct result of such policies, 
several resistant populations of plant pathogens have been reported
14
, and plant diseases 
caused by plant pathogens, including bacteria, represent a major cause of crop loss
17
.  It is 
therefore worth considering that the threat to human health posed by drug-resistant 
bacteria in agriculture may be just as great, or even greater than that posed by infectious 
human diseases, as in agriculture drug resistance threatens both the quantity and safety of 
the food supply, with food-borne infections currently among the most serious and costly 
global health concerns
18
.   
Two obvious strategies present themselves when considering means to combat the 
increasing emergence of drug-resistant bacteria.  The first would be to remove or reduce 
the causative factors of bacterial drug-resistance by implementing policies promoting 
responsible and efficient use of antibiotics, thus reducing “selective pressure” as much as 
is feasible.  The second of course, is the development or discovery of novel antibiotics 
with unique mechanisms of action which may yet be effective against bacteria otherwise 
resistant to existing therapeutics.  To this end, there has been a renewed interest in 
exploring “medicinal plants,” or plants used in traditional medicine, as possible sources 
of such pre-existing novel antibiotic compounds.  As research of plants for antibiotic 
compounds is, in recent years if not historically, a relatively underexplored field of study, 
there is consequentially a lack of standardization in the experimental methods and 
techniques used in such research.  Unfortunately, this discord may limit the ability of an 
investigator to accurately assess the antibacterial potential of a plant, while also making 
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the recognition of significant results, and the comparison of results from separate 
investigations, difficult.  The following therefore begins with an explanation of the 
reasoning behind the investigation of plants, specifically medicinal plants, as a source of 
novel antibiotic compounds, then provides a summary and some evaluation of the 
experimental methods and techniques currently used in this field as they relate to plant 
selection, chemical extraction, antibiotic screening, the identification of compounds of 
interest, and the determination of the mechanisms of action of antibacterial compounds. 
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II. LITERATURE REVIEW 
 
Why Plants? 
 There are several arguments to be made in support of the research of plants, and 
medicinal plants in particular, as potential sources of novel antibiotic compounds with 
which to combat drug resistance.  The first of these arguments is to point out the 
historical role that plants have played in the promotion of human health.  A medicinal 
plant, as defined by the World Health Organization, is a plant which contains substances, 
in one or more of its parts, which can either be used directly for therapeutic purposes, or 
are precursors for chemo-pharmaceutical semi-synthesis
14
, and it is important to consider 
that plants have served as the starting point for many of the modern pharmaceuticals in 
use today.  Indeed, it has been estimated that more than a full quarter of prescribed 
medications in industrialized nations derive their origins either directly or indirectly from 
plants
19
.  As this historical role relates specifically to plants providing a source of novel 
antibiotics for the treatment of infectious diseases, it is believed that plants possess 
secondary metabolites, in various plant tissues, which are produced and used by plants 
for defensive purposes
20,21
.  It has been postulated that these compounds are an 
evolutionary response to protect the plants from insects, predators, and most importantly 
in this context, microbes
11,22,23
, and this postulation is directly supported by the discovery 
that syntheses of some of these compounds occurs post-infection
24
.  It is therefore 
reasonable to hypothesize that some of these compounds produced to fight bacterial plant 
pathogens may also be beneficial in combating bacterial human pathogens. 
Second, plants in general are overwhelmingly abundant, yet vastly underexplored.  
There exist an estimated 2.5 million species of higher plants, and a large number have yet 
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to be studied in this context
25,26
.  India alone for example, where much of this type of 
research in the reviewed literature originates, possesses within its borders approximately 
130,000 plant species encompassing some 120 families
10
.  In North America, while 
Native Americans are believed to have used an estimated 2,500 plant species in their 
traditional medicine practices, the region is believed to contain as many as 20,000 native 
species
27
.   Plants thus represent a potentially vast source of bioactive molecules, which is 
likely why they have been referred to as the “sleeping giants of the pharmaceutical 
industry”19.  Further, while recognition of the antiseptic qualities of medicinal plants date 
to antiquity, efforts to characterize these properties in the laboratory setting date only to 
the early 1900s
28
.  In fact, the approximately 12,000 secondary metabolites so far isolated 
from plants are believed to comprise less than 10% of the total in existence
20
.  Therefore, 
it is entirely plausible that investigation of previously untested plant species will reveal 
medicinal plants possessing unrecognized antibiotic activities. 
The third argument to be made in favor of the research of plants as sources of 
novel antibiotic compounds is to note that the use of medicinal plants in the practice of 
traditional medicine persists very prominently even today.  The World Health 
Organization estimates that 80% of people in developing countries engage in such 
practices
23
, a number which corresponds to approximately 65% of the global population.  
The antimicrobial activity of plant extracts and oils has led to their administration as food 
preservatives, natural therapies, alternative medicines and pharmaceuticals
29
.  While it 
can be pointed out that there is often little solid scientific evidence to support such claims 
touting the antibiotic attributes of medicinal plants, it can also be reasonably argued that 
without thorough scientific evaluation, it would be inappropriate to summarily dismiss 
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their virtue.  Additionally, given the prevalence of their use, it is necessary to ensure the 
safety of these plants, as insufficient patient awareness or improper use result in many 
cases of adverse reactions in traditional medicine, including, among others, allergic 
reactions, fever and vomiting
1
.  Also, in cases where products derived from these plants 
are indeed found to be beneficial to human health, there is a need for standardization in 
terms of raw materials, production methods and quality control of finished products
1
.  
Such safety and standardization issues could be addressed through the increased 
investigation of these medicinal plants. 
 Additional arguments to be made in support of the investigation of plants as a 
potential source of novel antibiotics relate to the potential advantages such products could 
provide over synthetic antibiotics.  There currently exists a public mistrust of synthetic 
antimicrobials stemming from the potential toxicity or even carcinogenicity of these 
products
30
, as the use of synthetic antibiotics for example, may in some cases be harmful 
to distinct organs and threaten consumer health
31,32
.  Further, the application of synthetic 
antimicrobials in agriculture creates additional opportunities for human exposure to such 
chemicals, either through the consumption of chemical residues on crops, or bio-
accumulated chemicals in agricultural animals.  Antimicrobials may also be applied to 
finished food products for preservation and safety purposes, to protect against natural 
spoilage processes and pathogenic microorganisms, respectively
33
.  Consequentially, 
consumers are increasingly demanding minimally processed foods, at the same time 
desiring products free from pathogens, yet simultaneously containing fewer synthetic 
preservatives
18,33
, with mounting pressure from both consumers and legal authorities for 
alternative, natural product shelf-life extending additives
30
.  These demands are becoming 
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reflected in public policy.  In Europe for example, in-feed antibiotics for livestock were 
banned by the European Union as far back as 2006
34
. 
It is noteworthy that plant-derived substances have already served as food 
preservatives for centuries, with many herbs and spices used in food seasoning in fact 
also yielding useful medicinal compounds
35
.  Additionally, there are some positive results 
reported for medicinal plants used as animal feed in the reviewed literature.  They have 
been reported to promote growth and appetite, as well as have immunostimulatory and 
anti-pathogen effects in fish and shrimp aquaculture
12
 for example, and it has been 
suggested that prophylactic administration of immunostimulants and pro-, pre- and 
synbiotics is the most promising method of disease control in aquaculture animals
36
.  
However, it is important to note, as described previously, that there are also existing 
reports of adverse reactions to traditional medicines.  Though the fact that an antibiotic is 
derived from a natural source may sway public opinion to view it as less hazardous, there 
are no guarantees to be made as to the advantages, in terms of safety, of substituting 
plant-derived antibiotics for synthetic antibiotics.  Still, it is possible that further plant 
investigations may identify novel, and comparatively safer antibiotics for clinical and 
agricultural applications.   
Also, from an environmental perspective, the use of plant-derived antibiotics 
would seem greatly advantageous over the use of synthetic antibiotics.  Plant-derived 
substances, in their natural states, would likely be entirely biodegradable, and thus avoid 
pollution and environmental degradation issues related to orthodox medicines
37
.  Lastly, 
in comparison to synthetic antibiotics, using plant-derived antibiotics would lessen cost 
and increase the accessibility to these medications.  The possibility, at least in some 
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locales, of being able to culture medicinal plants and perhaps even purify or otherwise 
concentrate substances of medicinal value would be of great benefit to the destitute or 
those living in geographic areas without reasonable accessibility to modern medications. 
Thus, given their history as a medicinal source and the number of plant species which 
have yet to be investigated, their widespread use in traditional medicine and the need to 
ensure the safety of these practices, as well as the advantages their use may provide over 
that of synthetic medications, in terms of safety, environmental impact and cost, there is a 
solid case to be made in favor of the increased and expanded exploration of plants as 
potential sources of novel antibiotics.         
Plant Selection 
Studies of plants that investigate their therapeutic potential are typically screening 
exercises for the evaluation of antioxidant, anti-inflammatory, antifungal or antibacterial 
properties of plant extracts, and are usually based on ethnobotanical leads
38
.  The general 
strategy of these screening exercises as it pertains specifically to the evaluation of 
antibacterial properties of the plant can be broken down into several steps; plant selection 
is naturally the first of these steps.  There are both practical and logistical limitations to 
consider however, before finalizing the selection of a plant or plants for study.  In the 
search for novel antimicrobial compounds, as there are so many species from which to 
choose, plants with a long standing history of medicinal use constitute the most practical 
starting point
21
.  For example, Tchouya et al. conducted ethnopharmacological surveys in 
Gabon to identify fifty-two species of medicinal plants used there to treat HIV/AIDS-
related opportunistic diseases, prior to selecting five for phytochemical screening and 
antibacterial testing
5
.   
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However, the availability or accessibility of a medicinal plant must also be taken 
into consideration before a selection is finalized.  If the plant(s) of particular interest 
require crossing national boundaries to obtain, the likelihood of encountering proprietary 
ownership issues, as well as the monetary cost, may both increase.  Additionally, if it is 
believed that proprietary issues may arise, estimations should be made prior to the 
beginning of work, as comprehensively as possible, regarding how much plant sample 
will be necessary to complete the intended studies.  It then needs to be determined if it is 
possible to procure this amount of plant material, as well as to do so over a reasonable 
period of time.  For example, if a plant(s) is only accessible by means of agreement with 
a private botanical collection, either foreign or domestic, there may be strict limits 
imposed on the amount of plant material provided.   
Further, if limits are imposed, and on-site cultivation of plants is unfeasible, it 
should be considered that these limits may unduly prolong studies, potentially creating 
further issues related to the continuity of the researchers involved, cost, etc., as well as 
possibly causing variability in experimental results due to chemotype differences in the 
starting material.  These chemotype differences, even among members of the same plant 
species, may result from geographic
39
 or seasonal growth variations.  Smida et al., for 
example, in investigating the antibacterial activities of Ludwigia peploides and Ludwigia 
grandiflora over a period of several months, documented time-dependent differences in 
plant extract efficacy versus multiple strains of bacteria
40
, suggesting temporal 
differences in plant chemotype.  Further, the specific microenvironment in which a plant 
is grown may also affect its chemotype.  According to “plant defense theory,” defensive 
versus growth allocation of plant resources may depend upon the specific light 
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environment in which the plant grows, with plants growing in open habitats likely to 
contain higher levels of defensive compounds and reduced herbivory in comparison to 
those growing in shaded environments
41
.  Thus, as the geographical location, time of 
sample collection and the microenvironment in which a plant was grown may affect its 
chemical composition, limited accessibility to a plant may cause difficulty in obtaining 
plant samples capable of providing consistent experimental results, and this should also 
be considered prior to the selection of a plant for study.   
The selection of which plant part(s) to study is an additional consideration in 
study design.  While it has been stated that antibacterial compounds are more likely to be 
located within growth buds, young leaves, reproductive organs and parts of annual 
growth
20
, it is quite evident from the literature that different plant parts possess varying 
chemotypes, and that antibacterial compounds are not universally relegated to specific 
tissue types.  For example, Yasanuka et al., in testing the antibacterial potential of various 
Mexican medicinal plants, created extracts from fruits, heartwoods, leaves, fruit peels, 
roots, stems and twigs, and reported differences in results between plant parts from the 
same species
26
.  The inclusion and separate study of all parts of a selected plant in search 
of these differences, while appealing, adds substantially to the potential workload and 
financial cost.  Hypothetically, the separate study of individual plant parts is not 
mandatory, and whole-plant extracts may certainly be used in these screening exercises.  
However, as will be discussed below, there exists the possibility that if an antibacterial 
compound(s) present in a plant under study are relegated specifically to one plant part, 
inclusion of additional plant parts in the creation of an extract may dilute the 
concentration of this compound(s) to levels low enough to impede detection in 
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antibacterial assays.  Here again, it would be wise to consult traditional practitioners or 
users of the medicinal plant(s) of interest, so that plant parts selected for study match 
those used in practice.   
However, the selection of a specific plant part(s) may also increase the logistical 
difficulty of obtaining samples for study.  The harvest of a crop can significantly alter the 
future growth patterns of a plant population.  Mooney et al., for example, found both the 
number of flowering stalks and the proportion of these flowering stalks to leaves reduced 
in Ligusticum porteri populations up to two years post-harvest of rhizome and 
adventitious root material
41
.  Generally speaking, the harvesting of plant leaves is more 
sustainable than that of stems or roots
42
.  Therefore, individual suppliers may be 
understandably reluctant to provide stem or root samples of their plant(s).  Thus, the 
determination of what plant part(s) is of greatest interest, and how this may affect 
procurement of plant samples, should also be considered when selecting a specific 
plant(s) for study.  In conclusion, while it is in the best interest of the researcher when 
choosing a plant(s) for study to make practical selections based on ethnobotanical leads, 
it is also important to take into account how logistical issues pertaining to plant 
procurement may affect both the availability of plant material and its potential 
consistency in terms of chemical composition, as well as how the inclusion of various 
plant parts for study might further complicate this procurement, as well as potentially 
inflate workload and cost.    
Methods of Extraction 
Beginning with the treatment of plant material prior to the creation of chemical 
extracts, there appears in the literature a notable lack of standardization in the 
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experimental methods and materials used in this and in subsequent steps of these plant 
investigations.  For example, after sometimes being washed with water, plant material is 
almost always dried prior to chemical extraction.  However, plant material may be dried 
in the light or in the shade, for varying periods of time, and at different temperatures, and 
there is no rationale provided by the authors for their method selection.  Kuppusamy et al. 
for example, washed Commelina nudiflora plant material twice in running tap water prior 
to cutting the material into small pieces, then drying it in the shade at 35°C in 12-hour 
cycles of light and dark
31
.  Alternatively, Voravuthikunchai and Limsuwan, in sampling 
parts of eight species used in traditional medicine in Thailand, simply cut plant material 
into small pieces and dried these samples overnight at 60°C
43
, whereas Kenny et al. by 
comparison, sliced and freeze-dried dandelion roots prior to extraction
44
.   
Presumably, the purpose of drying plant material is to eliminate excess water and 
increase the concentrations of any antibacterial compounds present in order to enhance 
the probability of detection.  However, even such a commonplace practice as drying plant 
material prior to extract creation must be questioned.  Alabri et al. for example, reported 
the comparatively enhanced antimicrobial efficacy of several chemical extracts derived 
from fresh Datura metel leaves in comparison to similar extracts created from dry leaf 
material when tested against multiple bacterial species
27
.  It is therefore possible that 
drying risks the loss of volatile compounds in the plant material, potentially lessening 
antibacterial potential.  Regardless of the cause for differential antibacterial results 
between fresh and dried plant material, a sound investigation of a single plant may 
require testing of both.   
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Following drying, plant parts are then often, but again not always, ground or 
pulverized.  In the abovementioned studies, both Kuppusamy et al. and Kenny et al. 
powdered dried plant material using mechanical blenders, the former following this step 
with sieving of blended material through a 40 µm mesh
31,44
, whereas Voravuthikunchai 
and Limsuwan, using a similar approach, crushed dried plant material in a mechanical 
mortar
43
.  The use of grinding or pulverization is presumably to increase surface area 
exposure and enhance extraction efficiency, which is defined below.  This enhancement 
likely improves the chances of recognizing any antibacterial compounds potentially 
present within the plant material, by increasing the odds that these compounds will be 
present in the resulting extracts in high enough concentrations as to be detectable in 
antibacterial assays.   
In the pharmaceutical sense, the creation of extracts from plant material refers to 
the separation of therapeutically active constituents, with simultaneous elimination of 
unwanted insoluble material through treatment with selective solvents
45
.  However, 
extraction efficiency or extract yield, meaning the amount of extract produced per 
amount of starting material, may vary by plant part or by solvent used, or even when 
different methods are applied using the same solvent in treatment of the same plant 
material
45
.  This potential variability was illustrated by Kaneria et al. for example, during 
an investigation of the antibacterial and antioxidant properties of five plants traditionally 
used as health supplements in Saurashtra folk medicine.  A cold percolation method was 
used to create successive petroleum ether, ethyl acetate, methanol and aqueous extracts 
from a part(s) of each plant, and it was found that extract yield variability resulted not 
only among the five plants, but also between parts of individual plants
4
.  Therefore, some 
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trial and error may be unavoidable in efforts to optimize extract yields from a plant or 
plant part(s) selected for study.   
Solvent choice and the methods employed in the treatment of plant material with 
selected solvents vary greatly.  Additionally, solvent to plant material ratios are not 
standardized, or even discussed in the reviewed literature, thus once again, a trial and 
error method may be necessary to determine at what ratio most efficient extraction yields 
are achieved.  Commonly selected solvents appearing in the literature include acetone, 
ethanol, ethyl acetate, n-hexane, dichloromethane, methanol, water, n-butanol, petroleum 
ether and hydro-alcoholic mixtures, though additional solvents appear as well.  Akeel et 
al., for example, used sodium acetate buffer and sodium phosphate citrate buffer, the 
latter at six separate pH values, in the extraction of peptides and proteins from seeds of 
six plant species used in traditional medicine
35
.  Alternatively, Roy et al. used chloroform 
and chloroform with added hydrochloric acid in chemical extractions of the medicinal 
herb Andrographis paniculata, claiming that this plants metabolites are known to be 
extracted at higher yields in more acidic solvents
46
.   
Given the number of solvent possibilities, it would once again be reasonable, at 
least initially, to attempt to replicate the solvent choice, if not the entire extraction 
methodology, used in traditional folk medicine or phytotherapy for the specific plant(s) 
under study
25
.  For example, if the plant of interest is typically prepared and administered 
as a tea (water solvent) or tincture (alcohol solvent), it would be reasonable to perform 
extractions using these same treatment methods and solvents to best refute or support 
claims of therapeutic value.  In the screening of twelve northwestern Argentinian plants 
used in folk medicine, Soberon et al. for example, prepared infusions, decoctions and 
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tinctures in accordance with traditional practices, and found that both the aqueous and 
alcoholic extracts of Tripodanthus acutifolius demonstrated antibacterial efficacy against 
several strains of bacteria comparable to those of commercially available antibiotics
25
.      
There are also a number of different methods in the reviewed literature by which 
solvents have been applied to plant material in the creation of extracts, with most if not 
all investigations relying on a single method.  Again however, there is little rationale 
provided by the authors to justify the application method selected.  Some methods are 
very obvious or straightforward.  Using Voravuthikunchai and Limsuwan again as an 
example; crushed Thai medicinal plant material was simply soaked in 95% ethanol for 7 
days at room temperature
43
.  In a similar approach, Aqil et al. soaked powdered material 
from four Indian medicinal plants in a 70% ethanol solution for 8-10 days, stirring the 
mixture every ten hours
10
.  In a slightly more complicated approach, Regazzoni et al. 
stirred dried and minced Rhus coriaria leaves in cold water bubbled with nitrogen gas, 
claiming this helps avoid polyphenol oxidation
47
.   
Simple boiling or other heat-based treatments appear in the literature as well.  
Stanojevic et al. for example, created an aqueous extract from dried and ground Salvia 
officinalis leaves by cooking in a water bath at 80°C
48
, while Ganie et al. used a Soxhlet 
extractor at 60-80°C to produce a methanol extract from powdered Arnebia benthamii 
plant material
49
.  Though these heat-based methods may potentially increase extract 
yields in comparison to non-heat requiring methods, they may also risk denaturing or 
destroying heat-labile antibacterial proteins or compounds.  The length of heat exposure 
may be a deciding factor in some cases.  Kousha and Ringo for example, reported the 
stronger efficacy, against some bacterial strains, of aqueous extracts created from 
17 
 
Heracleum persicum and Heracleum mantegazzianum plant material which were 
prepared by 2 or 24 hours of boiling, in comparison to an identical extract which was not 
subjected to any heat-based treatment.  Yet in several comparisons, extracts derived from 
2 hour-boiling treatments demonstrated more antibacterial potency than those subjected 
to 24 hours of treatment
36
.  It is therefore possible in this study that while 2 hours of 
boiling may have enhanced the extraction of an antibacterial compound(s) in comparison 
to the non-heat-based treatment, 24 hours of boiling resulted in the subsequent 
degradation of these compounds.  Thus, the application of heat-based methods of 
extraction may in some cases result in a tradeoff between extract yield and the 
antibacterial potency or efficacy of the extract.   
In one interesting comparative study of techniques, Kothari performed extractions 
from seeds of five plants (Annona squamosa, Manilkara zapota, Phoenix sylvestris, 
Syzygium cumini and Tamarindus indica) using water, methanol or ethanol solvents, and 
employing five different treatment methods:  Soxhlet extraction, ultrasonication, 
continuous shaking at room temperature, and microwave extraction with or without 
intermittent cooling.  Though various attributes of the created extracts were measured, it 
was the Soxhlet method that was concluded to be the best method in terms of extract 
efficiency.  However, other methods were reported as resulting in extracts with superior 
antibacterial activity.  Thus, the authors concluded that no single method is likely 
superior for the extraction of all types of bioactive metabolites
45
.  It is therefore 
unfortunately very likely that a good deal of trial and error, combining the same starting 
plant material with various preparation methods, solvents, and treatment methods, may be 
necessary to detect the antibacterial properties of the plant under study, assuming they 
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exist.  Again, as such trial and error may add substantially to workload and cost, 
reference to the preparation and treatment methods applied in traditional medicine for the 
plant under study may help guide successful strategies. 
The creation of an extract solution through the treatment of plant material with a 
solvent(s) may be achieved using independent treatment, sequential treatment, or by 
fractionation of pre-existing solutions created using other solvents.  Independent 
treatment involves the application of a single solvent to a single sample of plant material.  
This will likely provide the greatest extract yields, though these results are likely to vary 
by solvent, as each solvent will likely fail to extract compounds of polarity greatly 
dissimilar to that of its own.  Water, being the universal solvent, constitutes the most 
logical starting choice for the chemical extraction of plant material, as compounds found 
therein are very likely to be soluble in an aqueous environment.  However, solvents of 
intermediate polarity, such as alcohols, may enhance the extraction of compounds 
possessing both polar and non-polar moieties.  Methanol, for example, has been claimed 
to be superior to water, ethanol and hexane in the extraction of antibacterial 
compounds
2,50
.  A potential advantage of an independent treatment strategy is that if 
solvents of different polarities are applied independently to separate samples of the same 
plant material, a collection of solutions is created that likely encompasses a large number 
of the compounds present in the starting material.  Jesionek et al. for example, used 
methanol, ethanol and ethyl acetate to create multiple extracts from dried plant material 
of each of three species: Sambucus nigra flos, Melisa officinalis and Viola tricolor
51
.  
However, such a strategy increases the amount of starting plant material required, and has 
the additional potential disadvantage of resulting in final extracts containing large 
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numbers of compounds for subsequent identification should an extract(s) demonstrate 
antibacterial activity.   
Sequential treatment is the application of multiple solvents to a single sample of 
plant material.  Rocha-Gracia et al., for example, treated samples of eighteen Mexican 
plant species, with one or more solvents each, using the following polarity-based order of 
solvent application:  n-hexane, acetone, ethyl acetate, methanol, ethanol, and a methanol-
water mixture
20
.  Similar to the independent treatment of multiple plant material samples 
using different solvents, a sequential treatment strategy such as this may be used to 
extract compounds of widely differing polarities.  Sequential treatment also provides the 
advantage over independent treatment of requiring only a single sample of plant material.  
However, if more than one of the solvents being used in sequential treatment withdraws a 
compound(s) possessing antibacterial activity from the plant material, and these solvents 
do so with different efficiencies, it is conceivable that the compound(s) of interest could 
be dispersed among the final extracts in low enough concentrations to the point where 
detection of antibacterial activity could be hindered. 
Fractionation is accomplished by the addition of a different solvent to a pre-
existing extract solution.  Lee et al. for example, in testing seven edible plants from 
Thailand in efforts to identify alternative antibiotics for feed additives, first fractionated 
methanol extract solutions using n-hexane/water mixtures, then further partitioned the 
resulting aqueous layers by means of sequential treatments with chloroform-water, ethyl 
acetate-water and butanol-water mixtures
34
.  Fractionation allows for the enhanced 
partitioning of compounds of slightly different polarities into separate solutions in 
comparison to independent or sequential treatment, and reduces the number of 
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compounds for identification.  However, though this enhanced allocation may improve 
the chances of detecting a compound(s) with antibacterial activity by increasing its 
concentration in a single extract solution, the fractionation of every solution created by 
independent or sequential treatment of a plant material sample is likely to increase cost 
and workload.  Therefore, it may be desirable to reserve fractionation for extracts which 
have already displayed antibacterial activity.     
Additional factors complicating the extraction process, which are nearly 
impossible to predict, are those of antagonistic or additive effects between 
phytocompounds in the same crude extract.  For example, in investigating the 
antimycobacterial effects of compounds found in Fructus Euodiae, Hochfellner et al. 
reported antagonistic effects between indoloquinazoline alkaloids and the quinolone 
alkaloid evocarpine, both of which were present in the original plant material
52
.  It is 
therefore possible that if an antibacterial compound(s) exists within a plant, but is 
normally physically sequestered from an antagonistic compound(s) in another plant part, 
that the use of whole plants, or particular solvents in the creation of an extract may result 
in the antibacterial activity of the first compound being masked if the two are 
simultaneously withdrawn from the plant material.  Conversely, it is also possible that a 
chosen strategy for extract creation may fail to simultaneously withdraw compounds 
which would otherwise act in concert to exert antibacterial effects.  Once again, as 
exhaustive testing of these possibilities would mandate the physical separation of every 
compound present in the plant material, it would once again be advisable to consult the 
preparation methods used for the plant under study in traditional medicine for reference 
in planning initial experiments. 
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Following solvent treatment of plant material, insoluble matter can be removed 
from the resulting solution, if so desired, using means as simple as the passage of the 
liquid through cotton, cloth or filter paper.  Adwan and Mhanna for example, filtered 
water extracts made from plants obtained in Palestine using Whatman No. 2 filter paper 
under vacuum
53
.  However, a single passage through materials such as these is unlikely to 
remove all insoluble matter.  Perhaps for this reason, Motz et al. for example, first 
vacuum filtered methanol extracts of Impatiens capensis using a Whatman Grade 1 filter, 
then repeated the process using a Whatman Grade GF/F filter
54
.  However, multiple 
filtrations increases the amount of extract likely lost to absorption by the filter material.  
Centrifugation, alone or followed by filtration of the supernatant, may provide a viable 
alternative.  Tolmacheva for example, in the creation of extracts from Eastern European 
medicinal plants, centrifuged aqueous or ethanol solutions at 1000 times g for 10 min, 
then passed the supernatants through 0.2 µm polyethersulfone syringe filters to ensure the 
sterility of the final products
55
.  Dried extracts can also be sterilized.  Chatterjee for 
example, subjected dried Vangueria spinosa extracts to UV exposure for 24 hours, then 
streaked samples on nutrient agar plates to monitor for contamination
56
.  However, it is 
possible that such irradiation may inadvertently cause photochemical reactions to occur 
within the extract.   
Following filtration, excess chemical solvent may need to be removed from the 
extract solution.  Removal of excess solvent not only increases the concentration of the 
plant compounds in the final solution, but is also necessary if the solvent is insoluble in 
the media intended to be used for antibacterial testing, or if the solvent itself is toxic to 
bacteria.  Exposure to an open air environment, the use of a laminar flow hood, and 
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biosafety cabinets represent simple options for solvent removal.  Alabri et al. for 
example, evaporated methanol, hexane, chloroform, ethyl acetate and butanol solvents 
from Datura metel extracts by simply allowing them to dry in a fume hood
27
.  However, 
at room temperature, these simple methods are likely to be time consuming.  Without the 
application of heat, water or water-based solvents in particular, can be very difficult to 
remove.  Lyophilizing of these extracts provides a good alternative method, if available, 
and use of this technique appears numerous times in the reviewed literature.  Yildirim et 
al. for example, in the creation of extracts from Turkish medicinal plants, lyophilized a 
filtered aqueous solution with a freeze-dryer at -65 °C, while for alcoholic filtered 
solutions, the solvents were first removed via rotary evaporation under vacuum at 60 °C, 
following which these were dissolved in distilled water and also lyophilized
28
.   
Heat-based methods of solvent removal however, such as the use of rotary 
evaporation, a speed vacuum concentrator, or even a water bath, similar to heat-based 
extraction methods, may damage heat-sensitive compounds.  Perhaps to minimize this 
heat degradation risk, Ocheng et al., in creating extracts from Ugandan plants used in the 
treatment of oral/dental diseases, first removed the solvents from filtrated hexane and 
methanol solutions using rotary evaporation until volumes of approximately 50 ml were 
reached, then dried the remaining solutions using an oven at 40-50 °C
42
.  It is reasonable 
to expect that during either solvent application or removal, exposure to temperatures 
greater than those to which the plant under study would normally be exposed in a natural 
environment might result in at least some level of chemical degradation within the plant 
material, and control experiments may be useful in exploring this possibility.   
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Two unique methods of extract preparation appearing in the reviewed literature 
meriting discussion are those of essential oil preparation and supercritical fluid 
extraction.  Obtained by steam distillation of plant material, often using a Clevenger-type 
system, essential oils are mixtures of volatile compounds which often carry the aroma 
and scent of the plant
7
.  Liquid, limpid, and mostly colorless
18
, these oils can 
subsequently be dehydrated through the use of various drying agents.  Salehi et al., for 
example, used anhydrous sodium sulfate in the removal of water from an essential oil 
prepared from the hydrodistillation of Ziziphora clinopodioides subsp. rigida plant 
material
57
.  By relying on an aqueous solvent, this method has the advantage of producing 
an extract free from organic solvents.  However, as high temperatures are applied, as 
discussed above, there exists the potential for thermal degradation of plant peptides and 
compounds
7
.  Additionally, essential oil production has the shortcoming of being unable 
to extract metabolites of large molecular mass
7
.   
By comparison, supercritical fluid extraction subjects solvents to higher than 
critical temperatures and pressures higher than critical pressures, giving the solvent a 
high density, yet allowing it to retain its diffusion ability.  As a result, the solvent can 
more easily penetrate the plant material.  Pressure reduction then converts the solvent to a 
gas, separating it completely from the liquid or semiliquid extract, providing a solvent-
free sample
7
.  Further, thermal degradation of peptides or other compounds can be 
avoided by using carbon dioxide for the extraction of plant material, which requires 
temperatures of only about 40°C
7
.  Additional advantages of SFE, similar to microwave 
assisted or ultrasonic assisted extraction, are the reduction in organic solvent 
consumption and relative minimal sample degradation
45
.  Thus, as it potentially offers 
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good yields and can circumvent the problem of thermal degradation of plant compounds, 
this second method appears to have advantages over more commonly used chemical 
extraction methods, and may very well see greater favor of usage in the future. 
Though not completely analogous to extracting antimicrobial compounds from 
plants, another recently developed technique which appeared several times in the 
reviewed literature is the application of plant extracts in the biosynthesis of metallic 
nanoparticles, which has become an important branch of this field
58
.  These synthesized 
nanoparticles are believed to have antibacterial properties, and may prove useful in 
topical applications, such as the coating of medical devices for sterility purposes
59
.  Ionic 
silver, for example, is believed to be capable of causing cell death by inactivating 
bacterial enzymes, inhibiting DNA replication and damaging the bacterial cell 
membrane
60
.  These antibacterial properties can be enhanced by using plant extracts as 
capping ligands, which are believed to inhibit aggregation by binding to the nanoparticle 
surface, thereby enhancing their water solubility and stability
60
.  The advantages of 
nanoparticle formation using plant extracts include being simple, cost-effective and easily 
scaled up to large production, as well as reducing waste products, improving efficiency, 
and being eco-friendly
58,59
.  Therefore, while not directly applicable to the treatment of 
infectious diseases, nanoparticle production from plant extracts may help reduce the 
spread of pathogens via nosocomial means, while also averting some of the negative 
environmental and financial consequences of synthetic bactericidal use.   
Antibacterial Testing  
The ultimate goal of antibacterial testing in plant studies is the determination of 
the minimum inhibitory concentration (MIC), the minimum extract concentration at 
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which growth of a specific strain of bacteria is halted, and/or the minimum bactericidal 
concentration (MBC), the minimum extract concentration at which a specific strain of 
bacteria is killed.  Though there is little standardization in terms of the antibacterial 
assays employed in the testing of plant extracts, the techniques appearing in the reviewed 
literature are very similar to those used in synthetic antibiotic evaluations.  The Kirby-
Bauer test, or disc diffusion assay for example, is the standard antibacterial assay in 
widest use
23
, and is also often used in plant extract testing in the literature.  Extract-
treated discs are placed on solid media plates which have been inoculated on the entirety 
of their surfaces with bacterial cultures.  During incubation, as the bacteria attempt to 
grow to complete confluence, the extracts diffuse from the discs, and those extracts 
containing antibacterial compounds create clearings, or zones of inhibition, surrounding 
the discs.  The antibacterial potency of an extract can be estimated by comparison of the 
size of its zone of inhibition to that created by a synthetic antibiotic control.  The disc 
diffusion method therefore provides a relatively easy and inexpensive means of testing 
multiple extracts against a single pathogen at one time.  
However, the disc diffusion method has several potential drawbacks.  Obtaining 
zones of inhibition uniform in diameter necessitates even impregnation of the disc with 
the extract
21
, which is not necessarily easily accomplished by hand.  Soaking of the disc 
in an extract prior to use may represent a preferable alternative.  However, to allow for 
disc soaking, the extract will need to be in liquid form, or re-suspended in solvent if it is 
dry.  The choice of solvent for extract suspension is important in disc diffusion assays, as 
the solubility of the extract, or the solvent in which it is suspended, can affect the rate of 
diffusion in the growth media being used, thereby influencing the distance travelled from 
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the disc
4,10,22
.  This can potentially diminish the size of a zone of inhibition if the extract 
or solvent are not completely soluble in the growth media used for the disc diffusion.  
The disc diffusion assay is therefore not suited to antimicrobial compounds or plant 
extracts which are insoluble or scarcely soluble in water
61
.  
 Further, the initial bacterial inoculum level
21
, the growth rate and metabolic 
activity of the microorganism being assayed in the media used
4
, and the temperature at 
which the assay is conducted
22
, may similarly prejudice the size of zones of inhibition, as 
an extract’s antibacterial efficacy may, for example, be masked by overwhelming 
inoculum levels or particularly virulent growth, both of which may be temperature-
dependent.  It may therefore be best to reference existing literature pertaining to the 
specific strain(s) of bacteria under study to mimic bacterial inoculum levels and 
temperatures employed in studies of other extracts or synthetic antibiotics.  As a result of 
these drawbacks, the disc diffusion method is considered an essentially qualitative, non-
standardized method, primarily useful only for the preliminary screening of multiple 
samples in a single assay
2,22
.   
An essentially identical method which appears in the reviewed literature is the 
agar well diffusion method, wherein uniform holes, or “wells”, are punched into solid 
growth media and filled with liquid extract samples.  In the antibacterial testing of 
extracts and fractions from ten species of Indian medicinal plants, Aqil et al. for example, 
first spread test organism inoculums on the surface of Muller-Hinton agar plates, then 
punched 8 mm wells in the media, filled these wells with 100 µl of plant extracts each, 
and incubated the plates overnight before measuring zones of inhibition
62
.  However, 
bacterial inoculums can also be mixed directly into the media.  This direct-mixing 
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method was used by Khan et al. for example, in testing the antibacterial activities of 
extracts created from Gloriosa superba rhizomes.  Bacterial cultures were diluted in 
cooled molten agar prior to plate pouring, and wells were then eventually dug into the 
solidified, bacteria-containing media
19
.  While the well-punching method eliminates 
concerns regarding the uneven distribution of the extract in treated discs, extract 
solubility and diffusion rates in the media, as well as initial bacterial inoculum levels, 
virulence and temperature, still represent variables capable of influencing results.   
An alternative approach is to pre-treat the media surface or the media itself with 
the plant extract under study before applying the bacterial inoculum.  For example, using 
the slanting tube method, wherein media is solidified in a vessel tilted at an angle to 
increase surface area, Jiang et al. treated solidified potato dextrose agar growth media 
with Blumea balsamifera “volatile oil” samples prior to inoculation with plant pathogenic 
fungi, citing the minimal oil concentration capable of preventing visible growth as the 
MIC
63
.  By contrast, Weckesser et al. mixed plant extracts and isolated compounds 
directly into Mueller-Hinton and Wilkins-Chalgren agar prior to inoculation with 
bacterial strains and yeasts of dermatological relevance, though an almost identical 
criterion for MIC evaluation was used
64
.  However, mixing plant extracts in the media, 
while potentially eliminating the diffusion problems inherent to disc usage or wells, only 
allows for the detection of the presence or absence of bacterial growth, with no 
quantitative zone of inhibition measurement, with results still susceptible to bacterial 
inoculum level, virulence and temperature influences. 
The microbroth dilution method, in which the growth of bacteria in extract-treated 
liquid media is measured, is arguably the strongest of the described techniques for the 
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antibacterial testing of plant extracts.  Provided the extract or the solvent in which it has 
been suspended is soluble in the liquid media, extract homogeneity should be easily 
achieved.  Further, more accurate quantitation of results is possible using this method, 
either through visual, colony counting, or spectroscopic means.  For example, growth 
inhibition in a microbroth sample can be easily assessed by visual inspection of the 
sample for a lack of cloudiness or turbidity indicative of bacterial growth, though this is a 
somewhat subjective measurement.  Antibacterial efficacy can also be quantified by 
diluting and plating extract-treated samples on nutrient agar plates and counting colony 
forming units after incubation, a method used for example by Wojnicz et al. in examining 
the effects of extracts derived from medicinal plants used in urinary tract infections on a 
clinical Escherichia coli strain
65
.  However, this method is likely to be time consuming.  
Spectroscopic means however, such as microplate readers, can be used to provide quick 
and specific quantification of bacterial growth.  The measurement of the optical density 
of a culture sample at a wavelength of 600 nm for example, indicates the amount of light 
scattering by bacterial cells, which correlates to cell density or growth
59
.     
However, when using the microbroth dilution method, the effect of initial 
bacterial inoculum levels and temperature on experimental results remain potential 
concerns.  Additionally, a common problem encountered when using the microbroth 
dilution method is that plant extracts may possess color
22
.  Coloring in an extract can 
complicate the evaluation of test samples when relying on growth detection methods such 
as visual inspection for turbidity or spectroscopic means.  For example, when visually 
inspecting a sample, coloring or particulate matter in an extract may make it difficult to 
discern turbidity attributable to bacterial growth from that resulting from these extract 
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properties.  Similarly, when using spectroscopic means to evaluate microbroth test 
samples, initial optical density levels may be significantly inflated by the addition of 
extract, in comparison to the optical density attributable to the media and the bacterial 
inoculum.  It will therefore be difficult to detect bacterial growth in these extract-treated 
samples until they reach optical density levels surpassing those of the initial test mixtures.  
Therefore, when using spectroscopic means, to account for the optical density of the 
extracts, as well as the media and the bacterial inoculum, the optical density of extract-
treated samples should be measured after extract addition, but prior to incubation, so that 
these initial values can be subtracted from post-incubation measurements.  Still, in 
comparison to solid-media based methods, the microbroth dilution method allows for 
more accurate quantification of MIC levels, the simultaneous screening of combinations 
of different plant extracts and bacterial strains in the same sample, and is more 
economical in terms of time and resources required
61
.     
Colorimetric indicators, such as tetrazolium salts, which living bacteria convert to 
colored formazan derivatives, can be added directly to extract-treated samples, and also 
allow for a quantifiable method of detecting bacterial growth
61
.  Eldeen et al. for 
example, applied the salt p-iodonitrotetrazolium violet to microbroth dilution bacterial 
samples treated with extracts derived from trees used in South African traditional 
medicine, interpreting the appearance of a red color as indicative of bacterial growth
1
.  
Alternatively, Tekwu et al. added Cameroonian plant extracts and bacterial cultures to 
Mueller Hinton Agar containing glucose and the pH indicator phenol red, which turns 
yellow upon acidification of the media in the event of metabolism of the added sugar by 
living bacteria
2
.  The detection of ATP in living cells may provide another means of 
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detecting bacterial metabolic activity, and can be assayed using the reagent Bac-Titer 
Glo™ with a plate reader61, a method used by Mekinic for example, in the investigation 
of the antibacterial properties of selected Lamiaceae species
66
.  Other colorimetric 
indicators appearing in the reviewed literature include the tetrazoium salts TTC
61
, MTT
51
, 
and Nitro blue tetrazolium
67
 and the dye resazurin
11,68,69
 (also known as Alamar Blue). 
However, the use of colorimetric indicators, in the reviewed literature at least, is 
done for MIC determination.  A lack of metabolic activity demonstrated by colorimetric 
indicators does not necessarily imply that the treated cells have been killed.  Additional 
testing is necessary to discern whether plant extract antibacterial effects, if present, are 
bacteriostatic or bactericidal in nature, or at what concentration effects may become 
bactericidal.  Bactericidal effects can be confirmed by a lack of observable growth after 
transfer of extract-treated samples to fresh media.  For example, in examining the 
antibacterial activities of Humulus lupulus components against bacterial strains believed 
to play a role in the etiology of acne vulgaris, Yamaguchi et al. plated microbroth dilution 
samples displaying no visible growth onto agar plates, then incubated these plates and 
observed them for lack of bacterial growth in order to determine bactericidal 
concentrations
70
.  Similarly, Weckesser et al. again for example, first mixed plant extracts 
or single plant compounds directly into agar plates, inoculated and incubated these plates, 
then excised and streaked inoculation spots displaying no visible growth onto fresh plates 
for MBC determination, choosing the lowest MIC concentrations failing to demonstrate 
visible growth after transfer
64
.  If a plant extract is found to be bactericidal, time-kill 
assays, using liquid media, are a useful means of quantifying the bactericidal potency of 
the extract.  Transfer of extract-treated samples to fresh media at various time points 
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allows for a measurement of the length of exposure necessary for lethal effects to be 
exerted.  Leandro et al. for example, in investigating the antibacterial efficacy of the 
compound dehydroabietic acid, derived from Pinus elliottii, removed aliquots from 
treated samples of Staphylococcus epidermidis at time points of 30 minutes, 6, 12 and 24 
hours, then serially diluted, plated, and observed these samples for visible growth after 
incubation
68
.   
As another consequence of the lack of standardization in this field of research, 
there is a wide discrepancy in the reviewed literature with regards to the working 
concentrations of extracts used in antibacterial assays.  In the aforementioned evaluation 
of Salvia officinalis extracts, Stanojevic et al. for example, reported testing concentrations 
as high as 40 mg/ml
48
, while Hussain et al. assayed concentrations as high as 100 mg/ml 
in the evaluation of extracts from plants used in traditional medicine in Pakistan
71
.  
Remarkably, Ugoh et al. reported testing concentrations as high as 500 mg/ml when 
evaluating the effects of Khaya senegalensis stem bark extracts on a subspecies of 
Salmonella enterica
3
.  It is important to consider that besides the potential experimental 
influences described earlier, such as inoculum level or temperature, antibacterial assay 
results for plant extracts may also be affected by factors such as salt formation, 
precipitation, autofluorescence, or antioxidant properties of the extracts
22,61
.  
Consequently, the use of such extreme concentrations as those described above increases 
the probability that one or more of these potential influences will adversely affect assay 
results.  However, it may be possible to account for at least some extract property 
influences experimentally.  When investigating the potential of several organic acids and 
plant extracts in food preservation applications, Over et al. for example, in an effort to 
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preclude pH effects as a contributing factor to antibacterial efficacy, included control 
samples with pH values titrated to match those of organic acid-treated samples
72
.     
There is also an apparent lack of agreement as to what constitutes a desirable or 
relevant MIC value for a plant extract, which likely contributes to the use of the extreme 
working concentrations described above.  Prior to sub-fractionation or the isolation of an 
individual compound(s), the crude state of the initial extract and the potentially low 
concentration of the compound(s) responsible for its antibacterial activity
46
, if present, 
will likely result in high experimental MIC values in comparison to those of synthetic 
antibiotics.  Consequently, acceptable or meaningful MIC levels for extracts are 
subjective, as the concentration of any antibacterial compound(s) is unknown.  It has 
been suggested that crude extracts and essential oils demonstrating antibacterial effects at 
or below concentrations of 100 µg/ml are promising candidates for potential 
pharmaceutical use, while for an isolated compound, this number drops to 10 µg/ml, and 
preferably less than 2 µg/ml
40,68
.   
Synergistic relationships among extracts, or between extracts and synthetic 
antibiotics, are explored numerous times in the reviewed literature.  The exploration of 
extract/extract combinations is justified when it is remembered that traditional healers 
often use combinations of plants in disease treatment
56
.  For example, Aqil et al. reported 
synergistic antibacterial effects among four Indian medicinal plant extracts, as well as 
between these extracts and synthetic antibiotics, in testing against a number of clinical 
MRSA strains
10
.  Similarly, Adwan and Mhanna reported reductions in synthetic 
antibiotic MIC values against Staphylococcus aureus clinical strains when applied in 
combination with aqueous extracts of plants obtained in Palestine
53
.  Chatterjee et al. as 
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well, reported an ethanol leaf extract of Vangueria spinosa as lowering the MIC values 
and enhancing the time-kill assay results of the synthetic antibiotics doxycycline and 
ofloxacin when combined in the treatment of numerous bacterial strains
56
.   
Mutagenicity, toxicity, and stability testing of plant extracts are not always 
included in the literature articles reviewed, but are certainly necessary components of a 
thorough investigation.  As noted by Eldeen et al., there exist claims of plants used in 
traditional medicine having displayed mutagenic effects in in vitro assays.  Therefore, in 
the aforementioned screening of extracts derived from trees used in South African 
traditional medicine, this group employed the Ames test with a strain of Salmonella 
typhimurium, considering the extracts “active” if the number of revertant colonies after 
incubation doubled that of the untreated control
1
.  Direct toxicity of plant extracts 
towards eukaryotes can be tested using numerous cell types and animals.  Owais et al. for 
example, evaluated the safety of Withania somnifera extracts by monitoring for lysis of 
treated and incubated human erythrocytes using hemoglobin absorbance readings at 600 
nm
73
.  By comparison, Miceli et al. tested for Borago officinalis and Brassica juncea 
extract lysis of sheep erythrocytes by observing for the failure of treated and incubated 
cells to form a pellet after centrifugation
13
.  Using in vivo methods, in the aforementioned 
Jiang et al. study of Blumea balsamifera, “volatile” oil-treated prawn larvae were 
evaluated by microscopy after cultivation to determine lethal effects
63
.  Alternatively, 
Toyang et al. tested the toxicity of a Vernonia guineensis extract using a slight 
modification of the 2000 World Health Organization method for assessing the acute 
toxicity of medicinal plants, in which the extract was administered to Sprague-Dawley 
rats by oral gavage, and the animals monitored for behavioral changes for a period of 
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seven days prior to surviving specimens being euthanized and necropsied
74
.  Finally, use 
of plant extracts in different applications also requires that the extract be quite stable
30
.  
To evaluate stability, Miceli et al. again for example, tested extracts before and after one 
year of storage at room temperature, 4°C and -20°C, and reported the loss of antibacterial 
efficacy versus the seven bacterial strains showing greatest sensitivity prior to extract 
storage for all temperature treatments assessed
13
.   
If plant extracts are being considered for use in agricultural or food preservation 
applications, such intentions necessitate additional evaluations.  Previous research has 
demonstrated that the intrinsic properties of food, including fat, protein, water or salt 
content, water activity, pH, the presence of other additives, antioxidants or preservatives, 
partition coefficients, and extrinsic determinants such as processing and storage 
temperatures, storage atmosphere, vacuum packaging, air and gas levels, as well as target 
microorganism characteristics and the interactions between these factors, can influence 
bacterial sensitivity to antibacterial compounds and may require higher extract 
concentrations in comparison to those demonstrating efficacy in in vitro assays
18,33
.  
These influences may be the result of the binding or inactivation of antibacterial 
compounds by food components or additives, or changes in extract solubility or phase 
distribution
13,33
.  Another possibility is that the greater nutrient availability in food 
compared to that in growth media may result in faster bacterial cell damage repair
33
, thus 
diminishing potential antibacterial effects.  For example, Miceli et al. tested their Borago 
officinalis and Brassica juncea aqueous extracts using three food model systems (meat, 
fish and vegetable broths), and reported that in vitro concentrations demonstrating 
antibacterial efficacy failed to do so in these models.  However, these extracts did show 
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antibacterial effects when applied at ten times the levels used in the in vitro assays
13
.  
Similarly, Klancnik et al. evaluated the antibacterial potency of commercial rosemary 
extracts versus L. monocytogenes and E. coli in food models of meat, vegetable, and 
dairy products, and reported that the type of food model tested influenced MIC results, 
with higher values registered for high-protein and high-fat meat and dairy products, as 
opposed to vegetable models
33
.  In an encouraging report of synergistic effects, 
Abdollahzadeh et al., in testing various plant essential oils and extracts for antibacterial 
activities versus Listeria monocytogenes, found the essential oil of thyme, alone and in 
combination with the antimicrobial peptide nisin, to be effective in inhibiting the growth 
of this pathogen in minced fish samples.  However, the authors also noted that since 
nisin, when tested alone, was more effective in a model of cooked fish in comparison to 
the minced fish model, that the manner in which the food model is prepared may 
influence results
18
, thus making direct comparisons of MIC values among similar studies 
difficult.   
A complicating factor to the use of plant extracts in agricultural or food 
preservation applications is the potential effect(s) they might have on the organoleptic 
profile of treated products
13
.  Plant extracts may change food flavor or smell
13,18
, possibly 
making treated crops less appealing to agricultural animals, or making treated finished 
food products less palatable to human consumers.  Also, selective activity against 
particular strains of bacteria, without broad spectrum antibacterial effects, may be 
desirable if the extract is intended for use as a preservative in foods already containing 
bacterial cultures, such as yogurt or cottage cheese.  The selective inhibitory action of 
sinapic acid, which has been identified as a component of Bassica juncea by Engels et al., 
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in starter cultures, protective cultures, or probiotics for example, allows for the 
elimination of foodborne pathogens without growth or metabolic inhibition of the 
beneficial lactic acid bacteria present in these products
75
.   
Finally, without in vivo testing using animal or human subjects, the former 
appearing rarely in the reviewed literature, the latter appearing not at all, in vitro results 
alone are limited in their predictive ability of the usefulness of plant extracts as clinical 
antibiotics.  In the evaluation of plant extracts as potential oral antibiotics for example, it 
should be remembered that the gastrointestinal system significantly affects the final 
bioavailability of conventional medicines
38
, and that this is of particular relevance given 
that oral consumption is perhaps the most prevalent route of administration in traditional 
medicine.  The human stomach has a pH level of 1-2, while the small intestine contains 
numerous additional digestive enzymes and has a pH of roughly 5.1-7.5
38
.  It is difficult 
to predict how these environments will affect the final bioavailable concentration(s) of an 
antibacterial compound(s) present in an extract
53
.  However, some information regarding 
the potential effects of the digestive system can be obtained using simulated 
gastrointestinal fluids, which can be prepared and used in in vitro antibacterial assays.  
For example, using the 1990 U.S. Pharmacopoeia, Vermaak et al. created simulated 
gastric and intestinal fluids, and found that Tarchonanthus camphoratus extracts lost 
some of their antibacterial activity after exposure to simulated gastric fluid, and 
completely after exposure to simulated intestinal fluid, suggesting possible degradation of 
an antibacterial compound(s) in these environments.  Interestingly however, they also 
reported that one Agathosma betulina extract became active only after exposure to 
simulated intestinal fluid, suggesting the possible activation of an antibacterial 
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compound(s) in this simulated environment.  The authors therefore concluded that in 
vitro screening results may in fact both overestimate or underestimate in vivo 
antibacterial potential
38
.   
Methods of Isolation and Identification 
 The isolation and identification of the compound(s) present in a plant extract 
which are responsible for its antibacterial activity are steps not routinely included in plant 
investigations in the reviewed literature.  This may be the result, in some cases, of a lack 
of access to the necessary reagents or equipment for such analyses, while in other cases it 
is possible that the authors do indeed regard these plant investigations primarily as mere 
screening exercises, and leave such analyses for future studies.  In any event, the isolation 
of the active compound(s) in an extract demonstrating antibacterial activity is necessary 
for a more exact determination of MIC and MBC levels.  Identification of the 
compound(s) will reveal whether a novel antibiotic has been discovered, which may be of 
therapeutic value in combatting drug-resistant bacterial pathogens, or whether a 
previously identified naturally occurring compound has been found.  However, it is 
possible that an already discovered, and even commercially available, naturally occurring 
compound may have never been previously recognized as having antibacterial properties.   
Once again, as there again is no standardized protocol or preferred technique(s) 
for the isolation and identification of plant extract constituents, a wide variety of 
chromatographic, chemical, instrumental, and combinations of these methods appear in 
the reviewed literature.  Though some of the more advanced chromatographic and 
instrumental methods are clearly superior in terms of providing a detailed account of 
extract composition, the cost of such equipment is potentially prohibitive.  Yet there exist 
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a variety of less expensive, readily available methods, capable of detecting compound 
classes or individual compounds within a plant extract.  While an exhaustive discussion 
of the advantages and disadvantages of all these methods is beyond the scope of this 
written work, it is instead the author’s intent to focus on making the reader aware of the 
numerous methods of isolation and identification currently used in the analysis of plant 
extracts.   
Readily available methods for the detection of compound classes in a plant extract 
often involve simple chemical assays using reagents which can be applied directly to the 
extracts, or to extract fractions separated by chromatographic methods.  Compound 
classes routinely identified in the reviewed literature using such methods, and which are 
believed in some cases to possess antibacterial activities, include alkaloids, amino acids 
and proteins, flavone derivatives such as flavonoids and flavonols, glycosides, iridoids, 
phenols and phenol derivatives such as phenolcarboxylic acids or  proanthocyanidins, 
saponins, steroids or sterols, tannins, and terpene derivatives such as terpenoids or 
triterpenoids.  Chemical methods employed in the reviewed literature for the detection of 
alkaloids in plant extracts for example, include colorimetric indicators such as 
Dragendorff’s reagent31, Hager’s reagent24, Mayer’s reagent73, Wagner’s reagent73, and 
the Marquis reagent, which is composed of a mixture of sulfuric acid and formaldehyde 
76,77
.  Similarly, the colorimetric indicator Ninhydrin can be used for the detection of 
amino acids or proteins
76,78
.  The presence of flavonoids in plant extracts can be 
confirmed using a colorimetric method involving magnesium powder and hydrochloric 
acid
78
, with variations of this method appearing in the reviewed literature as well, and 
being referred to as the “Shinoda test”24, “Shibata reaction” or “cyanide test”5.  A 
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separate, very simple colorimetric method that has also been used for flavonoid detection 
involves the observance of a yellow color change after the addition of sodium hydroxide 
to a hydrochloric acid-containing extract, or the disappearance of this color following the 
addition of the acid to a sodium hydroxide-containing extract
27,31
.    
The presence of glycosides can be confirmed using a colorimetric test known as 
“Legal’s test”, involving a pink to blood red color formation after extract treatment with 
dilute hydrochloric acid, followed by the addition of sodium nitroprusside in pyridine and 
methanolic alkali
24
.  Alternatively, Owais et al., in the aforementioned study of Withania 
somnifera extracts, used a modification of the colorimetric “Keller-Killani” test method 
as a means of glycoside detection, a longer method involving lead acetate, chloroform, 
glacial acetic acid, ferric chloride and sulfuric acid reagents
73
.  The presence of phenols 
can be confirmed by the appearance of a blue or green color
31
, or a bluish black color
24
 
following the addition of a solution of ferric chloride to a plant extract, or by a red color 
following the application of Fast blue B reagent
76
. 
Alternatively, the detection of saponins or saponosides actually requires no 
chemical treatment, and can be demonstrated by the observance of foaming after shaking 
of the plant extract
5,27,31, though a “blood reagent” can be used for chemical detection25.  
Steroids can be detected in plant extracts using variations of a colorimetric method 
involving chloroform and sulfuric acid known as “Salkowski’s test”27, or the “Libermann 
Burchard test”, a slight variation which includes the use of acetic anhydride24,31,79.  The 
Libermann Burchard test can also been used to detect sterols and triterpenes
5
.  Tannins 
can also be detected using this method
27
, or by the observation of a bluish or greenish 
black color following the addition of ferric chloride to an extract
31
.  Srinivas and Reddy 
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used a method wherein the formation of a white precipitate upon Pedalium murex extract 
mixture with a sodium chloride-containing gelatin solution indicated the presence of 
tannins
24
.  Similarly, Liao et al. also used a gelatin-based precipitation method for the 
detection of tannins in Polygonum capitatum extracts, which was followed by a vanillin-
hydrochloric acid-based method to identify tannin structural types
78
.  Finally, terpenoids 
can be detected by observing for a green color formation following the addition of a 
copper acetate solution to an extract suspended in water
24
.   
Quantification of the concentrations of some of these classes of compounds can 
also be accomplished using chemical methods coupled to some chromogenic or light-
based method, along with the use of a reference standard.  Bobis et al. for example, used 
spectrophotometric measurement after the addition of an aluminum chloride solution to 
extracts created from nettle, basil, thyme, costmary and yarrow, along with a quercetin 
reference standard, for quantification of total flavone/flavonol levels
80
.  The 
concentration of flavonol monomers in plant extracts can also be determined using a 
spectrophotometry-based method involving p-dimethylaminocinnamaldehyde, with 
epicatechin as a reference standard
66
.  To quantify flavonoid content, a 
spectrophotometric method based on the successive addition of sodium nitrate, aluminum 
chloride and sodium hydroxide solutions to an extract can be used, with butylated 
hydroxytoluene or quercetin serving as reference standards
31,80
, as can a separate method 
involving spectrophotometric quantification and the appearance of a yellow color 
following the addition of ethanol, aluminum chloride and potassium acetate solutions to 
an extract, also using quercetin as a reference standard
34
.  Total phenol or polyphenol 
content of plant extracts can be determined using the “Folin-Denis” method, also known 
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as the “Folin-Ciocalteu” method, involving treatment of plant extracts with a reagent of 
the same name and a sodium carbonate solution, followed by spectrophotometric analysis 
with reference standards such as tannic acid, gallic acid or quercetin
19,34,45,57,69,80-83
.  For 
the quantification of proanthocyanidins, Hori et al. for example, used the vanillin assay 
with d-catechin as a reference standard in the study of aqueous extracts of Azuki beans
84
.  
Alternatively, without spectrophotometry, the total tannin content of plant extracts can be 
measured using the Lowenthal method, which uses titration with potassium 
permanganate
85,86
. 
Chromatographic methods are useful in the fractionation of plant extracts prior to 
efforts to identify their contents.  By isolating, to different extents, the chemical 
constituents of an extract, these means of physical separation enhance identification, and 
such methods are often found to precede constituent analyses in the reviewed literature.  
Fractioning of an extract may be accomplished using as simple a method as paper 
chromatography.  Nemereshina et al. for example, combined one and two-dimensional 
paper chromatography with separate solvent systems for the fractioning of aqueous 
extracts of Plantago and Veronica species, prior to tentatively identifying individual 
compounds using the characteristic fluorescence of reagent-treated spots
85
.  Alternatively, 
Leandro et al. first used vacuum liquid chromatography to fractionate a “resin-oil” oil of 
Pinus elliottii with an n-hexane/ethyl acetate based solvent system of increasing polarity, 
followed by classic chromatography of the fraction demonstrating the greatest 
antibacterial efficacy, to eventually isolate the candidate compound dehydroabietic 
acid
68
.  Similarly, Joray et al. used vacuum liquid chromatography on a silica gel with a 
hexane-ethyl ether-methanol solvent gradient to fractionate an Achyrocline satureioides 
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ethanol extract.  The fractions demonstrating antibacterial activity were then subjected to 
successive column chromatography to produce sub-fractions, from which the candidate 
compound 23-methyl-6-O-desmethylauricepyrone was eventually isolated
67
.  In the 
aforementioned study of Fructus Euodiae, Hochfellner et al. used solid phase extraction 
and elution with acetonitrile/water solvents, followed by semi-preparative high pressure 
liquid chromatography (HPLC) of selected resultant fractions, to isolate the compounds 
evodiamine and rutaecarpine
52
.  By comparison, to collect hydrophobic fractions from 
extracts of Eastern-European medicinal plants, Tolmacheva et al. used reversed-phase 
column chromatography with an acetonitrile/water/trifluoroacetic acid elution mixture
55
.  
Using an extensive combinatorial approach, Liao et al., in the previously described study 
of Polygonum capitatum, employed macroporous resin column chromatography, MCl 
column chromatography and liquid column chromatography to fractionate an aqueous-
ethanol extract
78
.  Though it is technically not a chromatographic method, a dialysis 
treatment of dandelion root extracts was used in the aforementioned Kenny et al. study 
for fractionation according to molecular weight
44
.      
However, in addition to providing for physical separation, chromatographic 
methods can also provide for a tentative means of identifying individual compounds.  
When plant extract samples are run in tandem with reference compound standards, 
retention times and absorption spectra can be compared for identification, as well as 
quantification, purposes.  For example, in the previously described study by Mekinic et 
al., phenolic compounds in the sage, thyme, lemon balm, peppermint and oregano 
extracts were identified using HPLC, by comparing retention times and absorbance 
spectra with those of reference standards, and quantified by comparing peak areas with 
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those of external standard calibration curves
66
.  Similarly, Bobis et al., in addition to 
performing spectrophotometric measurements as described earlier, used HPLC with 
phenolic acid and flavonoid standards to identify and quantify these types of compounds 
in extracts of nettle, basil, thyme, costmary and yarrow
80
.   
Thin layer chromatography (TLC) represents a simple chromatographic method 
that may be very well suited to the investigation of plant extracts for antibacterial 
properties, and its use appears several times in the reviewed literature.  Similar to other 
chromatographic methods, reference standards can be used to tentatively identify 
compounds by comparing their distances migrated during physical separation, known as 
Rf values, to those of the reference plate spots.  Again using Srinivas and Reddy as an 
example, Pedalium murex extracts were separated using both thin layer chromatography 
and high pressure thin layer chromatography, with compounds tentatively identified by 
comparison of their Rf values to those of standard values
24
.  Also, chemical reagents for 
compound class identification can be applied directly to fractionated samples on the 
chromatographic plate.  Bashir et al. for example, used several of the aforementioned 
chemical indicators in the form of sprays in assessing compound classes present in thin 
layer chromatography-fractionated green tea extracts
76
.  Additionally, spots may be 
physically scraped or otherwise removed from the chromatographic plate, allowing for 
recovery of the fraction or compound(s) of interest
25
.  Further, thin layer chromatography 
provides for the possibility of analyzing many samples in one reaction, requires limited 
sample pre-treatment in comparison to high pressure liquid chromatography, for example, 
and allows for the evaporation of solvents used as mobile phase components, making it 
ideal for bioassays
51
.       
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The particularly suitability of thin layer chromatography to plant investigations 
comes from its use in a bioassay wherein completed gels are overlaid with growth media 
containing bacterial cultures.  Zones of growth inhibition may then be observed directly 
atop plate spots, thus readily identifying the fraction(s) or compound(s) possessing 
antibacterial activity.  Additionally, some of the chemical methods previously described 
for detection of growth inhibition can be applied directly to the plate spots for further 
confirmation of antibacterial activity.  Aqil et al. again for example, first fractionated 
Indian medicinal plant extract samples on silica gel thin layer chromatography plates, 
then overlaid the developed plates with nutrient agar containing methicillin-resistant 
Staphylococcus aureus.  After incubation, p-iodonitro-tetrazolium violet was applied to 
the plates to confirm the antibacterial activity of chromatogram spots surrounded by zone 
of inhibitions
10
.  Similarly, in the aforementioned study of Argentinian plants, Soberon et 
al. also overlaid dried TLC plates in bacteria-containing media.  Following incubation, 
the plates were covered with an MTT-buffer solution and incubated in the dark, after 
which the plates were observed for the appearance of yellow spots indicative of growth 
inhibition
25
.   
In comparison to chemical or chromatographic methods, advanced instrumental 
methods provide for a more definitive identification of the individual compounds present 
in a plant extract.  However, these instrumental methods are usually preceded by or 
coupled to a chromatographic method to fractionate the extracts prior to analysis.  In 
combination, comparison of chromatographic retention times and mass spectral results to 
those of reference standards recorded in pre-existing databases allows for a more 
definitive identification of individual compounds.  LC-MS, or liquid chromatography-
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mass spectrometry, for example, combines the physical separation capabilities of liquid 
chromatography with mass analysis capabilities
21
, and this coupling has seen increasing 
use in the structural characterization of complex matrices such as plant extracts
47
.  
Combining gas chromatography (GC) with mass spectrometry, Rodrigues et al. 
characterized essential oils derived from Mentha cervina by comparison of GC retention 
indices to those of a standard hydrocarbon mixture, and GC-MS spectra to a home-made 
library constructed from laboratory-synthesized components, reference oils and 
commercially available standards
39
.  Alternatively, Kuppusamy et al. compared gas 
chromatography-mass spectrometry results of various Commelina nudiflora extracts with 
those of standards using the National Institute of Standards and Technology database
31
.  
Finally, combining the use of internal and external databases, Salehi et al. identified 
individual compounds in the essential oil of the subspecies rigida of Ziziphora 
clinopodioides by first comparing GC-MS results to those of an internal reference mass 
spectra library and standard compounds, then confirming these results through 
comparison of retention indices to those of standard compounds and literature reports
57
.   
Multiple other uses of chromatographic techniques in combination with or 
coupled to instrumental analytical methods appear in the reviewed literature as well.  
Chaweepack et al. for example, followed HPLC with nuclear magnetic resonance 
spectroscopy and mass analysis to first isolate and then identify trans-p-coumaryl 
diacetate extracted from a galangal extract
87
.  Alternatively, Lu et al. combined ultra-
performance liquid chromatography with mass spectrometry in the analysis of tea, Galla 
chinensis and rhubarb extracts
88
, while Wojnicz et al. combined this chromatographic 
method with a quadrupole-time of flight mass spectrometry instrument in the analysis of 
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various extracts derived from plants used to treat urinary tract infections
65
.  In the 
aforementioned Kenny et al. study, flash chromatography, followed by liquid 
chromatography and solid phase extraction nuclear magnetic resonance, were employed 
in the analysis of dandelion root extract fractions, with further compound verification 
done using liquid chromatography-mass spectrometry
44
.  Dadasoglu et al. used gas 
chromatography with a flame ionization detector for quantitative characterization of the 
essential oils of various Origanum species, followed by the use of gas chromatography-
mass spectrometry for compound identification
89
.  Finally, in a somewhat unique and 
potentially very useful approach, Liu et al., in an investigation of Chinese plants used to 
treat snake bites, first partitioned the extracts demonstrating the greatest antibacterial 
efficacy directly into 96-well microplates.  The individual well contents were then tested 
for antibacterial activity, and the results for each were correlated against their HPLC 
retention times.  This allowed for identification of the compounds of interest, using 
HPLC coupled to high resolution mass spectrometry-solid phase extraction-nuclear 
magnetic resonance
90
.  One advanced instrumental method that may prove to be of 
particular use in the evaluation of plant extracts was described by Regazzoni et al. in the 
previously mentioned study of aqueous extracts of Rhus coriaria, wherein flow injection 
analysis was coupled to high resolution mass spectrometry.  According to the authors, 
this method provides the advantages, in comparison to a similar method using HPLC in 
place of flow injection, of requiring no chromatographic separation of extracts prior to 
analysis, having generally short analysis times, and needing no solvent consumption for 
liquid chromatography
47
.  Therefore, by eliminating the need for coupling to a 
chromatographic method, this method may simplify plant extract analysis and compound 
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identification.  However, it is possible that there exist other advanced instrumental 
methods capable of more efficient or more precise analysis offering similar advantages, 
which did not appear in the reviewed literature.   
Mechanisms of Action 
 Elucidating the specific mechanism of action by which a plant extract or 
compound exerts its antibacterial activity can help to predict its potential clinical or 
agricultural significance, either as a stand-alone antibiotic with a novel mechanism of 
action, or as an adjunctive therapeutic to be applied in combination with a pre-existing 
antibiotic(s).    Indeed, attempts to define mechanisms of action often appear as the final 
step of plant investigations in the reviewed literature.  Some of these antibacterial 
mechanisms may be broad spectrum in effect, meaning that the extract or compound(s) 
target cellular components or traits common to many bacteria.  In other cases, effects may 
be narrower in range, demonstrable against only a small number of species, implying a 
mechanism of action targeting a relatively unique cellular component or trait.  It is of 
course most desirable that a plant extract or compound will exert an antibacterial effect 
against a drug-resistant bacterial strain(s) through a novel mechanism of action, 
subverting drug-resistance capabilities.  However, it is also possible that an extract or 
compound will act only through inhibition of the means by which a bacterial species is 
conferred drug-resistance, making it useful only as an adjunctive therapeutic.      
Numerous bacterial resistance mechanisms to existing antibiotics and biocides 
have been identified and provide potential chemotherapeutic targets.  These include drug-
efflux pumps, porin deletion, drug metabolism in the periplasmic space, alterations to 
membrane fluidity, the over-production or alteration of the drug target
15
, biofilms, and 
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quorum sensing.  Drug efflux pumps are energy-dependent, integral membrane proteins 
capable of expelling antibiotics across the cell membrane against their concentration 
gradient
91
.  The majority of such pumps in bacteria are non-specific proteins able to 
recognize and expel a broad range of structurally and chemically unrelated compounds
6
, 
and are believed to play an important role in bacterial pathogenesis, virulence and biofilm 
formation
11
.  Porins, which are outer membrane proteins, are used by some small 
hydrophilic antibiotics as a means of entry to Gram negative bacteria
91
.  Thus, deletion of 
these proteins presumably bars these antibiotics from entering the cell and exerting their 
effect(s).  Alternatively, drug metabolism in the periplasmic space of Gram-negative 
bacteria is due to the presence of enzymes capable of breaking down foreign molecules 
introduced from outside of the cell
61
.     
In contrast to porin deletion, alterations to cell membrane fluidity presumably 
bestow drug resistance by restricting the passage of hydrophobic antibiotics into the cell.  
It has been reported that in Gram-negative bacteria, the evolution of the outer membrane 
in combination with drug efflux pumps has come to provide a significant permeability 
barrier to amphipathic compounds as well
11
, and it is possible that alterations to the 
fluidity of the outer membrane fluidity play a role in this means of antibiotic resistance.  
Alternatively, over-production or alteration of the drug target presumably lessens or 
negates antibiotic effects by either increasing the drug concentration necessary for the 
exertion of these effects, or rendering the antibiotics ineffective through elimination of 
the binding site, respectively.  Biofilm formation confers antibiotic resistance through the 
physical shielding of bacterial cells to drug exposure in an extracellular matrix.  After 
initial attachment to host tissues for example, Escherichia coli begin to grow and spread 
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on the surface as a monolayer, forming microcolonies which can eventually create 
biofilms
65
.  Cells contained within these biofilms are protected from antibiotic exposure 
by the extracellular material, and have been reported to be as much as 1000-fold more 
resistant to antibiotics in comparison to planktonic cells
91,92
.  Lastly, quorum sensing, or 
chemical communication among bacterial cells within a colony, potentially represents 
another drug-resistance mechanism, as it has been described as possibly regulating 
multidrug efflux pumps
91
.  It has also been reported that the use of a quorum sensing 
inhibitor in combination with an antibiotic may increase bacterial biofilm susceptibility
91
.   
While technically not drug-resistance mechanisms, other traits related to 
pathogenicity may provide additional opportunities for therapeutic interventions using 
plant extracts or compounds.  For example, adhesion to eukaryotic cells often represents 
the first stage in many microbial infections, and bacterial traits such as cell surface 
hydrophobicity, or the specific binding of bacterial adhesins to the host cell-surface, are 
believed to play a role in these bacterium-host interactions
43
.  Alternatively, some 
species, such as Pseudomonas aeruginosa for example, produce an extracellular shielding 
mechanism which confers resistance to the phagocytic activity of polymorphonuclear 
leukocytes
82
.  Therefore, as disruption of microbial adhesion or extracellular matrix 
formation by plant extracts or compounds may inhibit pathogenesis, these bacterial traits 
offer additional potential applications for plant extracts or compounds as therapeutics.  
A limited number of assays measuring plant extract or compound effects on some 
of the antibiotic resistance mechanisms described above are found in the reviewed 
literature.  Ohene-Agyei et al. used an in silico method to predict possible plant 
compound/drug efflux pump interactions, further confirming some of these predictions 
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using an assay designed to assess reductions in the efflux of the dye Nile Red as a 
measure of pump inhibition by these plant compounds.  Notably, they reported an 
increased sensitivity of drug-resistant bacterial strains to some synthetic antibiotics in the 
presence of these compounds
11
, suggesting that pump inhibition by the plant compounds 
prolonged the presence and activity of the synthetic antibiotics within the cells.  
Alternatively, to test the plant compound dehydroleucodine’s effects on biofilm 
formation, Mustafi et al. grew treated bacterial cells on polyvinyl chloride microtiter 
plates.  The plates were stained with a crystal violet solution, washed, and the number of 
remaining attached cells quantified by solubilizing the dye in ethanol and measuring it 
using spectrophotometric means
93
.  Tolmacheva et al., in the aforementioned study of 
Eastern-European medicinal plants, tested extract interference on quorum sensing 
abilities using the opportunistic plant pathogen Chromobacterium violaceum.  Production 
of the purple pigment violacein is controlled by the same system as is responsible for 
quorum sensing activity in this organism, thus making possible a colorimetric assay, 
wherein reduction in pigment levels may be interpreted as indicative of antagonism of 
quorum sensing by the tested extract
55
.   
Assays testing extract or compound effects on bacterial traits which do not 
provide a means of drug-resistance, but which still relate to pathogenicity, were more 
commonly found in the literature.  Wojnicz et al. for example, in the previously described 
investigation of plants used to treat urinary tract infections, tested extract effects on the 
microbial adhesion and biofilm formation capabilities of a clinical strain of 
uropathogenic Escherichia coli.  For example, the ability of extract-treated cells to 
aggregate in increasing salt concentrations was used to assess extract reductions in cell 
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hydrophobicity, while hemagglutination of human erythrocytes was used as a means to 
assess extract impact on P. fimbriae expression or function, which is believed to play a 
role in microbial adhesion to host tissue.  Additionally, the cell binding of congo red dye 
was used to assess extract effects on the expression of curli fibers, which may be 
involved in biofilm formation, while measurement of swimming zones was made to 
determine extract effects on motility, another virulence determinant in uropathogenic 
Escherichia coli strains
65
.  Similarly, Voravuthikunchai and Limsuwan, in their 
aforementioned investigation of Thai medicinal plants, tested extract effects on the 
microbial adhesion of enterohemorrhagic strains of Escherichia coli, using an almost 
identical salt aggregation test, wherein the ability of bacteria to aggregate in increasing 
ammonium sulfate concentrations in the presence and absence of plant extract was 
assessed using light microscopy
43
. 
Broad spectrum antibacterial mechanisms of action can be assessed as well.  For 
example, effects on bacterial membrane permeability represent a potentially important 
mechanism of action, as even sub-lethal injuries to the membrane can affect the cell’s 
ability to adequately osmoregulate or exclude toxic materials
15
, and these effects can be 
assessed using various assays.  Lu et al. for example, tested the effects of formulated 
plant extracts on the cell membrane of the aquatic pathogen Aeromonas hydrophila 
through means of visual inspection via transmission electron microscopy, by measuring 
treated cells for potassium leakage with atomic absorption spectrometry, and using flow 
cytometry to detect propidium iodide nucleic acid intercalation
88
.  Alternatively, 
Tomlinson and Palombo investigated Eremophila duttonii extract effects on 
Staphylococcus aureus membrane permeability using both detection of propidium iodide 
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binding and a salt tolerance assay, which measured the ability of treated cells to grow on 
sodium-supplemented agar after extract exposure
15
.   
Bacterial DNA damage by an extract or compound represents another broad 
spectrum mechanism of action, and can also be assayed.  Stagos et al. for example, in 
investigating the potential protective effects of Greek Lamiaceae species extracts against 
hydroxyl radical-induced DNA strand damage, also tested the extracts themselves for 
potential DNA damaging effects.  Gel electrophoresis of extract-treated pBluescript-SK 
plasmid DNA was used to detect conversion of supercoiled topological states to open and 
linear forms, which is indicative of DNA damage
30
.  Also, Ganie et al. investigated 
potential DNA damage by a methanol extract of Arnebia benthamii, using a similar 
methodology with the plasmid pBR322
49
.     
Comparison of the antibacterial testing results of an extract or compound versus 
bacterial strains with different phenotypes can also yield clues to its general mechanism 
of action.  For example, the detection of antibacterial activity against both Gram-positive 
and Gram-negative bacteria may indicate broad spectrum antibiotic compounds or 
general metabolic toxins
23
.  Alternatively, reduced efficacy versus Gram-negative in 
comparison to Gram-positive bacteria may indicate a mechanism of action impeded by 
differences in cell wall composition
8
.  In an investigation of the antibacterial efficacy of 
several Turkish plant extracts, Oskay et al. noted that the greater efficacy demonstrated 
by several of these extracts versus drug-resistant bacterial strains in comparison to the 
reference strains might be indicative of a unique mechanism of action
8
.  However, 
comparisons may also yield clues as to the specific nature of a mechanism of action.  For 
example, Ahmad et al. concluded that the increased inhibitory activities of Heydotis 
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capitellata and Heydotis dichota extracts against a DNA-repair deficient Bacillus subtilis 
strain in comparison to the wild-type was suggestive of a possible DNA inhibitory 
mechanism of action
94
.  Conversely, in other cases, such comparisons can also rule out a 
specific mechanism of action.  For example, Yasanuka et al. concluded that the similar 
efficacies of Mexican medicinal plant extracts against both methicillin-sensitive and 
methicillin-resistant strains of Staphylococcus aureus suggested that lactam rings could 
be ruled out as a possible mechanism of action
26
.   
 Multiple possible mechanisms of action have been ascribed to multiple classes of 
plant compounds in the literature.  Flavonoids for example, are believed to complex with 
both extracellular and soluble proteins, as well as detrimentally interact with enzymes 
essential for maintaining the stability of the cell wall
22
.  There have also been reports of 
flavonoid inhibition of enzymes involved in mycolic and fatty acid biosynthesis
5
.  
Further, it has also been suggested that flavonoids may exert antibacterial effects or 
inhibit pathogenesis by inhibiting nucleic acid synthesis, cytoplasmic membrane 
function, microbial attachment and biofilm formation
91
.  Biofilm inhibition, by 
flavonoids such as quercetin, kaempherol, apigenin and naringenin for example, has been 
attributed to suppression of autoinducer-2 activity, which plays a role in cell-to-cell 
communication
65
.  The toxicity of phenolics to bacterial cells has been ascribed to 
disruption of the cell membrane
95
, or possible non-specific protein interactions
69
.  
Catechins however, phenolic compounds found in green tea, have been reported to kill 
bacterial cells through specific inhibition of the enzyme DNA gyrase
76
.  Polyphenolic 
compounds have been postulated to exert antibacterial effects not only through disruption 
of the cell membrane, but also by causing liposome leakage, by generating hydrogen 
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peroxide, by exerting mutagenic effects, and/or by inhibiting or killing the cell through 
adsorbing onto the surface of the bacterial cell wall
84,96
.  Saponins may affect cell 
membrane permeability through the formation of plasma membrane pores, and may also 
interfere with enzyme activity
54
.  Tannins have been suggested to bind and form 
complexes with cellular enzymes, cell wall proteins and metal ions, and disrupt the cell 
membrane
90
.  Terpenes have also been claimed to act through cell membrane 
disruption
15
. 
General metabolic effects may be responsible for the antibacterial activity of 
some plant extracts and compounds.  Oxidative stress, for example, has been reported to 
be involved in the lethality of antibiotics exerting their effects through different 
mechanisms of action
97
, and this may be the case with some plant extracts and 
compounds as well.  It has been demonstrated that under antibiotic treatment, superoxide 
production results in the disruption of iron metabolism regulation, and the generation of 
highly toxic hydroxyl radicals
97
.  Autocidal activities resulting from free radical 
accumulation due to metabolic imbalance and impaired ionic homeostasis may thus add 
to the biocidal effects of antibiotics or plant extracts and compounds
15
.  For example, 
organic acids in plant extracts may act as antibacterial compounds when undissociated 
forms of the acids enter the cell and partially dissociate, thereby decreasing cytoplasmic 
pH and interfering with the proton motive force of the cell membrane
72
.   
Conclusion 
 There is a strong case to be made, based on several compelling arguments, for the 
increased exploration of plants, particularly “medicinal plants”, as a potential source of 
novel antibiotic compounds with which to treat drug-resistant bacteria.  Plants have a 
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longstanding history as a source of therapeutics used in both traditional and modern 
medicine, and the sheer abundance of plant species which have yet to be investigated in 
this regard suggests that this natural resource may be thus far underutilized.  
Additionally, plants and plant products are still in wide use as traditional medicine by 
much of the world’s population, thus there are benefits to be gained by assessing and 
improving the safety and standards of these products.  Further, plant-derived antibiotics 
may offer the additional benefits, in comparison to synthetic antibiotics, of lessened 
toxicity and side effects, biodegradability, reduced cost and increased accessibility.   
However, before they begin, the investigation of the antibacterial properties of 
plants can be complicated by logistical issues pertaining to the procurement of plant 
material for study.  These issues can directly impact which plant(s), which plant part(s), 
and what amounts may be obtained.  These impacts can affect experimental results, for 
example, due to potential fluctuations in the chemical composition of plants which may 
occur seasonally, or be dependent upon the geographic locations or microenvironments in 
which the plants were grown.  In consideration of potential logistical issues, and given 
the abundance of available species from which to choose, reference to traditional 
medicinal practices may provide useful in the selection of specific plants or parts for 
study. 
Additionally, the study of plants for the possession of novel antibiotic compounds 
is a field greatly lacking in the standardization of experimental methods.  For example, 
even the treatment of plant material prior to chemical extraction varies greatly, and the 
effects such treatments may have on experimental results in unknown.  Further, a wide 
variety of solvents and methods are used in the chemical extraction of plant material, and 
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all of these factors combine to affect extract yields, and possibly experimental results.  
However, as the presence or chemical composition of an antibiotic compound in a plant 
is unknown prior to experimentation, trial and error methods may be unavoidable in 
thorough investigations.  However, reproduction of traditional preparation and extraction 
methods can help refute or support historical claims of a plant’s medicinal benefit.   
This field of research is further hindered by the variety of assays used in the 
antibacterial testing of plant extracts.  The use of solid media assays versus microbroth 
dilution methods, as well as discrepancies in bacterial inoculum levels and working 
concentrations of extracts tested, makes study comparisons and recognition of potentially 
significant results difficult.  Further, studies often neglect to include assays for extract 
toxicity to eukaryotic cells or organisms.  Definitive identification of the compound(s) 
within a plant extract which are responsible for its antibacterial activity appears only 
sporadically in the literature, though this may be due in some cases to lack of access to 
more advanced instrumental methods.  Finally, testing of the mechanism of action by 
which the antibacterial effects of a plant extract or compound are exerted, are few in 
number as well.  Perhaps as a result, several plant compound classes are ascribed in the 
literature to exert antibacterial effects by a multitude of different mechanisms.   
 However, despite the difficulties inherent to these investigations, there is a 
preponderance of encouraging results to be found in these written works.  Crude extracts 
and compounds derived from plant material have demonstrated antibacterial activity 
against a wide array of disease-relevant bacterial species.  Importantly, they have also 
demonstrated an ability to enhance the efficacy of standard antibiotics when combined 
together in the treatment of these bacteria.  Given the number and chemical diversity of 
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plant compounds so far identified as possessing antibacterial properties, it is unreasonable 
to expect that a single chemical extraction procedure can be universally applied to all 
plant species, though adherence to historical practices may at least be useful in validating 
the efficacy of traditional medicines.   Still, in the future, standardization of the 
antibacterial testing methods used in this field, along with an increased emphasis on 
assaying drug-resistant bacterial pathogens, may help better identify which extracts and 
compounds are effective in concentrations low enough to be considered of therapeutic 
benefit, while standardization of toxicity assays may better ensure their safety.  
Nevertheless, the results appearing in the reviewed literature have further verified the 
existence of antibacterial compounds in a variety of plant species, and when it is 
considered that the overwhelming majority of species have yet to be investigated in such 
a manner, the continuation and expansion of this work appears to hold great promise.   
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III. MATERIALS, METHODS AND RESULTS 
Artemisia 
The genus Artemisia consists of some 522 species
98
 of annual or perennial 
shrubby or herbaceous plants
99
, belonging to the Anthemideae tribe of the Asteraceae or 
“Compositae” family100.  The genus is globally distributed amongst a variety of habitats, 
being found in northern temperate regions of Europe and North America, as well as in 
South America, southern Africa and the Pacific Islands
98,100,101
.  These plants possess an 
aromatic odor
99
, believed to be attributable to the presence of volatile terpenes
100
.  
However, the scent is similar to that of various salvia species, a genus of the Lamiaceae 
or “mint” family, and it has been suggested that it is this relationship which explains the 
“sage” portion of the common nomenclature for several Artemisia species, such as 
“sagebrush”, “sagewort” or “sageweed”102.    
Artemisia tridentata, in addition to being the most common shrub species found 
in the American West, is one of the most ecologically important and widely distributed 
shrub species in western North America, growing in dry mountain basins and high deserts 
ranging from British Columbia to Baja, and extending east through the Rocky Mountains 
and the Dakotas
100,102
.  It is the largest of the shrubs in this genus, growing as large as 
four feet, and serves both as an important habitat and food source for animals and 
invertebrates
100,102
.  The plant has a silvery gray appearance, with alternate leaves divided 
into three parts at their tips
102
.  The blooming period runs from July through September, 
with the flowers small, tubular, yellowish, and growing in loosely arranged terminate 
inflorescences
102
.   
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Artemisia species in general, and the tridentata species specifically, have 
extensive histories of use in traditional medicine.  Plants of this species are believed to 
possess bacteriostatic qualities capable of combatting various forms of infection, and 
have been used for such purposes in topical applications
102
.  Though they have also been 
used for internal applications, such as in the treatment of internal bleeding, such practices 
are discouraged by modern-day herbalists, due to potential liver and digestive tract 
toxicity
102
.  Historically, herbs from this genus have also been used, for example in 
Anatolian medicine, as tonics, for antimalarial and antihelmintic purposes, for diabetes, 
bronchitis, ulcers, tuberculosis, and in wound treatments
98
.  Artemisia species have also 
been reported to have been used to treat fever, malaria, tuberculosis and intestinal 
worms
101
.  Even today, these species are one of the most popular in Chinese traditional 
preparations, used for the treatment of malaria, hepatitis, inflammation and infections 
resulting from fungi, bacteria and viruses, as well as in cancer treatment
100
.   Further, the 
essential oils of these species are used in a variety of antimicrobial applications, including 
embalmment, food preservation, as microbicidals, as well as in applications as sedative, 
analgesic, spasmolytic, anti-inflammatory and local anesthetic remedies, with 300 
commercially important varieties important to the pharmaceutical, cosmetic, perfume, 
food, agricultural, and sanitary industries
100
. 
Artemisia tridentata is also seen in a variety of medicinal applications in modern 
times.  Mexican Indians in Colorado for example, use it in the form of tea or hot vapor 
baths to treat colds
103
.  Alternatively, New Mexico Spanish-Americans apply it in an 
external poultice to the umbilical stump in order to prevent infection, and to the small of 
the back as both an anti-infective remedy following miscarriage, and as a treatment for 
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menstrual cramps
103
.  The Navajo use this plant for a variety of medical purposes: 
employing its odor to treat headaches, using boiled plant material as a childbirth aid or 
for treatment of indigestion and constipation, for making a poultice used in the treatment 
of colds, swellings, tuberculosis and corns, or to make tea for the treatment of colds and 
fevers
103
.  The Hopi, Tewa and Zuni are also reported to use Artemisia species, including 
tridentata, for medicinal purposes
103
.   
Bacterial Species Assayed 
Staphylococcus aureus is a member of the genus Staphylococcus, comprised of at 
least 45 species of gram-positive, non-motile, spherical bacteria, approximately 1 µm in 
diameter, which often grow in irregular, grapelike clusters
104
.  They comprise some 
members of the natural microbiota of human skin and mucous membranes
104
.  In fact, it 
has been estimated that approximately 30% of all people are rhinal carriers of 
Staphylococcus aureus
105
.  Staphylococcus infection typically occurs through the 
formation of a furuncle, by means of contamination of a wound, through contamination 
of implanted medical devices, or via urinary tract infections
104
.  Infections resulting from 
some staphylococci may cause suppuration, abscess formation, pyogenic infections, or 
potentially fatal septicemia, while pathogenic species produce extracellular enzymes and 
toxins, and infections with these species may lead to blood hemolysis or plasma 
coagulation
104
.  It is noteworthy that the most common type of food poisoning results 
from ingestion of a staphylococcal heat-stable enterotoxin
104
. 
Staphylococcus aureus is the major human pathogen of this genus, and it is 
believed that most people will incur a Staphylococcus aureus infection at some point in 
their lifetimes, ranging from food poisoning and mild skin infections to more serious, 
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potentially fatal conditions, such as pneumonia, osteomyelitis, endocarditis, bacteremia 
and sepsis
104,105
.  Staphylococcus aureus and Staphylococci in general have become 
resistant to multiple antibiotics, due in part to the acquisition or development of the 
“Staphylococcal cassette chromosome,” a genetic element encoding a penicillin-binding 
protein enabling resistance to methicillin, nafcillin and oxacillin, though this element may 
contain genes conferring resistance to additional antibiotics as well
104
.  β-lactamase 
production is also observed in staphylococci, exclusive of the cassette chromosome, and 
imparting penicillin resistance
104
.  Vancomycin resistance is seen in this genus as well, 
resulting from alterations and proportional changes in cell wall components, while 
resistance to erythromycins, tetracyclines, aminoglycosides and other drugs is the result 
of plasmid-acquired resistance
104
.  Further, as mentioned above, staphylococci produce 
various enzymes and toxins important in their pathology.  In addition to enzymes such as 
clumping factor and coagulase, Staphylococcus aureus produces hemolysins, the toxin 
Panton-Valentine Leukocidin, exfoliative toxins, toxic shock syndrome toxin-1, and other 
enterotoxins
104
.   
In a 2014 World Health Organization (WHO) global surveillance study of 
antimicrobial resistance, the prevalence of infections due to methicillin-resistant 
Staphylococcus aureus (MRSA) strains among all Staphylococci infections was assessed.  
More than 25 percent of Staphylococci infections were attributed to MRSA in Southeast 
Asia, greater than 50 percent in some Eastern Mediterranean regions, greater than or 
equal to 60 percent in some parts of Europe, approximately 80 percent in some African 
regions, greater than or equal to 80 percent in the Western Pacific, and as high as 90 
percent in some regions of the Americas.  However, the data was admittedly incomplete 
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due to the difficulties of tracking these infections in countries without the policies and 
procedures in place to collect such information
106
.  Therefore, it is possible that the WHO 
estimates may in fact underestimate the prevalence of MRSA.  Finally, it was determined 
that those infected with a MRSA strain were 64% more likely to succumb to infections 
than were those infected with non-resistant strains, providing some metric of the potential 
mortality attributable to this drug-resistant species
106
. 
Pseudomonas aeruginosa is a member of the family Pseudomonadaceae, which 
consists of gram-negative, motile, aerobic rods, occurring widely in soil, water, plants 
and animals
104
.   Pseudomonas aeruginosa is the major human pathogen of the genus 
Pseudomonas, normally found in moist environments, in or on the human intestine or 
skin, and in hospitals
104
.  Infection is typically the result of bacterial circumvention of 
host defenses by means of a physically compromised site providing a route of entry, such 
as a burn, puncture wound or catheter for example
104
, with most infections nosocomial in 
nature and primarily affecting the immunocompromised, potentially resulting in 
infections of the blood, pneumonia, or post-surgery complications
107
.   More serious 
infections may manifest as fever, shock or oliguria, among other conditions, while milder 
manifestations include ear infections in children or skin rashes, both believed to be 
attributable to insufficiently chlorinated water in pools or hot tubs
104,107
.   
 Pseudomonas aeruginosa possesses fimbriae for host-cell attachment, and 
produces exopolysaccharide and sometimes lipopolysaccharide, the latter of which 
imparts some endotoxic effects and plays a direct role in the more serious infections 
described above
104
.  Also, most clinical isolates produce extracellular elastases, proteases 
and hemolysins
104
.  Further, Pseudomonas aeruginosa strains may produce the 
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necrotizing Exotoxin A, as well as exoenzymes S, T, U and Y, which are also toxins and 
are believed to cause cell death or adversely affect the host immune response
104
.  Centers 
for Disease Control data for Pseudomonas aeruginosa infections in the United States 
include 51,000 healthcare-associated annual incidences, 6,000 of which are attributable to 
multi-drug resistant strains, with 400 annual deaths
107
. 
Listeria monocytogenes is a member of the Listeria genus, and is a gram-positive, 
non-spore forming, facultative anaerobic motile rod
104
.  There exist 13 known serovars, 
with clinical isolates typically 0.4-0.5 µm in diameter and 0.5-2 µm in length
104
.  
Commonly found in soil, water and animals (CDC), this species is extremely resilient, 
capable of tolerating acidic and high salt environments, as well as refrigeration 
temperatures of 4°C
104
.  Listeriosis is the result of the ingestion of contaminated food or 
food products, such as uncooked or undercooked meats, vegetables or dairy products, 
though contamination may also occur during food processing at a manufacturing 
facility
108
.   Those most susceptible to infection or disease are newborns, the pregnant, 
the elderly, or the immunocompromised, with in utero transmission possible
108
.  Clinical 
manifestations in the immunocompromised include gastroenteritis, bacteremia, 
meningoencephalitis and septicemia, as well as neonatal sepsis and meningitis, and 
postpartum infections
104
.  Listeria monocytogenes is also known to cause disease in 
animals, both domestic and wild
104
. 
Listeria monocytogenes produces several adhesion proteins for the purposes of 
host-cell attachment, as well as internalins on its cell wall which promote phagocytosis 
by epithelial cells
104
.  The in vivo life cycle of this species transpires intracellularly 
among epithelial cells, macrophages and hepatocytes, allowing it to avoid exposure to 
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antibodies, complement or polymorphonuclear leukocytes
104
.  This complicates antibiotic 
therapy, as the drugs must enter the eukaryotic host cells to exert their effects
104
.  
According to the Centers for Disease Control, from 2000-2008, Listeria monocytogenes 
infections resulted in 1,600 illnesses each year in the United States, with 1,500 resultant 
hospitalizations and 250 annual deaths
108
. 
Salmonellae are members of the Enterobacteriaceae family, a grouping composed 
of gram-negative, mostly motile, flagellous, rod-shaped facultative anaerobes or 
aerobes
104
.  These are among the most common disease-causing bacteria, with 20-25 
clinically relevant species
104
.  Most are animal pathogens, and the animals they typically 
infect, such as pigs, poultry, rodents, pets and others, act as bacterial reservoirs.  
Salmonella enterica is one of two species of the Salmonella genus, which consists of 
greater than 2500 serotypes
104
.  It can be further divided into at least five subspecies, with 
enterica representing the subspecies of greatest clinical relevance to humans
104
. 
Salmonellae are also fairly resilient, for example, being capable of surviving in 
freezing water for extended periods.  Human infection or disease is the result of the 
ingestion of contaminated foods, such as meat products, shellfish, dried or frozen eggs, 
beverages such as water or milk and dairy products, recreational drugs such as marijuana, 
animal dyes and household pets
104
.  The most at-risk populations again are infants, the 
elderly, and the immunocompromised
109
.  Clinical manifestations include bacteremia, 
enteric fever, enterocolitis and possible systemic infection
109
.  According to the Centers 
for Disease Control, from 2000-2008, on an annual basis the United States witnessed 1 
million foodborne illnesses, 19,000 hospitalizations and 380 deaths resulting from non- 
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typhoidal Salmonella species, with an additional 1,800 annual illnesses and 200 annual 
hospitalizations due to Salmonella enterica serotype Typhi
109
. 
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Preliminary Plant Screenings 
Fifteen plants, from five families, were screened for potential antibacterial 
properties prior to the investigation of Artemisia tridentata.  The extracts tested were pre-
existing in the lab, having been created from the boiling of dried plant material in 
methanol, cotton filtration of the supernatant, solvent removal via rotary evaporation, 
desiccation, and suspension of the dried extract in dimethyl sulfoxide (DMSO) after 
solvent removal.  The species and family names of the plants from which each extract 
was derived, the concentration assayed, the number of samples run in the assay, and the 
incubation conditions are summarized in Table 1 below and appear in chronological 
order.     
 
Table 1:  Summary of preliminary plant screening assays 
 
All extracts were assayed against the following four species of bacteria:  
Staphylococcus aureus, Pseudomonas aeruginosa, Listeria monocytogenes, and 
Salmonella enterica.  Bacterial cultures were inoculated from frozen stock into Luria-
Broth (LB) and incubated with rotation overnight.  The following day, the cultures were 
diluted in 5 ml fresh LB to an approximate optical density reading of 0.100, measured at 
Species Name Family
Tested Extract 
Concentration 
Sample Repeats Assay Conditions
Garciadelia castilloae Euphorbiaceae 100 µg/ml Single 39°C and 235 rpm
Grimmeodendron eglandulosum Euphorbiaceae 100 µg/ml Single 37°C and 235 rpm
Lasiocroton bahamensis Euphorbiaceae 100 µg/ml Triplicate 37°C and 235 rpm
Omphelia ekmanii Euphorbiaceae 100 µg/ml Triplicate 37°C and 235 rpm
Phyllanthus epiphyllanthus Phyllanthaceae 100 µg/ml Triplicate 37°C and 235 rpm
Theophrasta jussieui Primulaceae 100 µg/ml Triplicate 37°C and 250 rpm
Catesbaea parviflora Rubiaceae 100 µg/ml Triplicate 37°C and 250 rpm
Cubanola daphnoides Rubiaceae 200 µg/ml Triplicate 37°C and 250 rpm
Cubanola domingensis Rubiaceae 200 µg/ml Triplicate 37°C and 250 rpm
Isadorea pungens Rubiaceae 200 µg/ml Triplicate 37°C and 250 rpm
Osa pulchra Rubiaceae 200 µg/ml Triplicate 37°C and 250 rpm
Pilea grandifolia Urticaceae 200 µg/ml Triplicate 37°C and 250 rpm
Phyllanthus myriophyllus Phyllanthaceae 600 µg/ml Duplicate 37°C and 250 rpm
Clavija domingensis Primulaceae 600 µg/ml Duplicate 37°C and 250 rpm
Pilea microphylla Urticaceae 600 µg/ml Duplicate 37°C and 250 rpm
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a wavelength of 600 nm (OD600).  Measurements were read using an Ultrospec 2100 Pro 
UV/Visible Spectrophotometer (Amersham Biosciences), and were taken again after the 
addition of sample treatments, and at 1, 2, 3, 4 and 24-hour time points post-incubation.  
Initial values, or the averages of values for samples run in duplicate or triplicate, taken 
after sample treatment but prior to incubation, were subtracted from all subsequent time 
point readings to account for the light dispersal contributions of the media, the 
antibiotics, and the extracts, the last of which were quite significant in many cases. 
Negative values were recorded as a reading of zero.   
Untreated bacterial cultures served as negative controls.  Initially, the positive 
controls for each bacterial species were as follows and were based on previously 
experimentally determined values (data not shown):  tetracycline at a concentration of 25 
µg/ml for Staphylococcus aureus, and amikacin at a concentration of 100 µg/ml for 
Pseudomonas aeruginosa, Listeria monocytogenes and Salmonella enterica.  However, 
after the first assay, the concentration of amikacin used as a positive control for Listeria 
monocytogenes was increased to 200 µg/ml, as the lesser concentration failed to 
satisfactorily inhibit bacterial growth for a full 24 hours. 
Under the specific conditions used in these assays, none of the methanol extracts 
demonstrated any discernable antibacterial effects against the bacterial species tested 
(data not shown).  This was despite increases in the extract concentrations assayed, as can 
be seen in Table 1.  Additionally, the growth curves observed for both the treated and 
untreated samples often dipped between the 3 and 4-hour time points, implying 
overgrowth of the culture in the volume of media used, likely attributable to an excessive 
initial inoculum level.   
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Initial Artemisia tridentata Assays 
 Artemisia tridentata leaves and stems were collected in November of 2012 in 
Ephrata, Washington, and their identity verified by botanist Dr. David W. Lee.  The plant 
material was placed inside a heated cabinet without light at approximately 80°F until dry.  
The first extract was created from this material by boiling 4.9758 g of mostly leaves in 50 
ml methanol (approximate 1 g/10 ml plant material to solvent ratio) with the use of a 
reflux condenser.  The material was boiled for approximately 45 minutes, and the 
resulting supernatant decanted and filtered through cotton.  50 ml of fresh methanol was 
added to the plant material, and the process was repeated.  The combined extracts were 
dried using a rotary evaporator, then placed in a desiccator under vacuum to remove any 
remaining methanol.  The final extract was then suspended in DMSO to a concentration 
of 100 µg/ml.   
This extract was tested for antibacterial properties in triplicate at a concentration 
of 100 µg/ml, employing the same experimental conditions as were used in the screening 
of the preceding fifteen plant extracts.  Bacterial cultures were grown overnight at 
approximately 37°C and 250 rpm for a period of about 16 hours and 30 minutes.  After 
dilution and treatment, samples were again incubated at approximately 37°C and 250 
rpm.  The Artemisia tridentata extract had no apparent growth inhibitory effects (data not 
shown).  Also, there was again evidence of bacterial overgrowth. 
These results came as a surprise, as an essential oil derived from this plant had 
been previously reported to inhibit the growth of Staphylococcus aureus
99
.  Therefore, the 
assay was repeated as before, running single extract-treated samples at concentrations of 
100, 500, and 1000 µg/ml.  Bacterial cultures were grown overnight at approximately 
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37°C and 250 rpm for a period of about 17 hours and 15 minutes.  After culture dilution 
and treatment, samples were again incubated at approximately 37°C and 250 rpm.  As 
can be seen in figures 1-4, this extract showed some growth inhibition of Staphylococcus 
aureus at the highest concentration of 1000 µg/ml, but only to a modest extent, and this 
effect dissipated after 4 hours, disappearing by the 23-hour mark (time constraints forced 
the last measurement to be taken one hour early).   
 
 
 
Figure 1:  S. aureus treated with A. tridentata methanol extract 
 
 
 
 
Figure 2:  P. aeruginosa treated with A. tridentata methanol extract 
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Figure 3:  S. enterica treated with A. tridentata methanol extract 
 
 
 
 
Figure 4:  L. monocytogenes treated with A. tridentata methanol extract 
 
A second methanol extract was made from the same Artemisia tridentata plant 
material for further testing.  2.0018 g of previously dried plant material, including leaves, 
some buds and stems, was boiled in 20 ml methanol (approximate 1 g/10 ml plant 
material to solvent ratio) with the use of a reflux condenser.  This material was boiled for 
approximately 45 minutes, and the resulting supernatant decanted and filtered, this time 
using Whatman #1 filter paper in an effort to reduce the amount of insoluble material in 
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the final extract.  20 ml of fresh methanol was added to the plant material, and the 
process was repeated.  The combined extracts were dried using a rotary evaporator, then 
placed in a desiccator under vacuum to remove any remaining methanol.  The final 
extract was then suspended in DMSO to a concentration of 100 µg/ml.   
The antibacterial assay was repeated using this new extract, running extract-
treated samples in triplicate, but only at a concentration of 1000 µg/ml.  Bacterial cultures 
were grown overnight at approximately 37°C and 225 rpm, for a period of about 19 hours 
and 20 minutes.  After culture dilution and treatment, samples were again incubated at 
approximately 37°C and 225 rpm.  A DMSO-treated sample, using a volume equivalent 
to the volume of extract added, was included as a vehicle control for each bacterial 
species.  As can be seen in figure 5 (results for other bacteria not shown), this extract 
exhibited only slight inhibition of Staphylococcus aureus, and tetracycline as a positive 
control failed to inhibit growth for a full 24 hours. 
 
 
Figure 5:  2
nd
 trial of S. aureus treated with A. tridentata methanol extract 
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Upon further review of the aforementioned paper, “Antibacterial Action of 
Essential Oils of Artemisia as an Ecological Factor,” from 1967, it was observed that the 
bacterial inoculum level used in that study was significantly lower than that used in the 
assays described above
99
.  The authors reported diluting bacterial cultures to levels of    1 
x 10
4
 to 10
5
 bacteria per ml prior to sample treatment.  However, they also reported 
essential oil treatments in terms of volumes added, with no concentrations given, thus 
direct comparisons to our treatments was difficult.  The number of bacteria giving an 
OD
600
 reading of 1.000 is believed to be approximately 8 x 10
8
 cells/ml
110
.  However, this 
number is representative of an Escherichia coli culture, and as Staphylococcus aureus 
possesses a different size and cell morphology, it likely disperses the light passed through 
a culture sample to a different extent, making the use of this number only an estimate.   
Therefore, the assay was repeated yet again to assess whether the mild inhibitory 
effect observed for Artemisia tridentata versus Staphylococcus aureus in the previous 
assays was due to the use of too high a bacterial inoculum level.  Extract-treated samples 
were tested in duplicate at a concentration of 1000 µg/ml.  Bacterial cultures were grown 
overnight at approximately 37°C and 225 rpm for a period of about 20 hours and 15 
minutes.  However, this time, overnight cultures were diluted to an OD600 value of 
approximately 1.000, following which 2 µl of these diluted cultures were used to 
inoculate 5 ml samples of fresh LB.  Based on the Escherichia coli optical density 
number, this should have resulted in a concentration of approximately 320,000 
bacteria/ml ([8 x 10
8
 cells/ml x 0.002 ml]/5ml).  This is significantly less than the 8 x 10
7
 
bacteria/ml used in the previous assays (based on the dilution of culture samples in those 
assays to an OD600 value of 0.100, the equivalent of a 10-fold dilution of a culture giving 
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an OD600 reading of 1.000).  After treatment and inoculation, samples were again 
incubated at approximately 37°C and 225 rpm.  DMSO-treated samples were included as 
vehicle controls.  OD600 readings were taken prior to incubation, and at 1, 2, 3, 4, 6 and 
24-hour time points.   
As can be seen in figure 6, overall growth of the Staphylococcus aureus cultures 
was slow, which would be expected given the low inoculum level.  However, the extract 
prevented detectable growth of Staphylococcus aureus through the 6-hour time point.  
Though this effect disappeared by the 24-hour mark, it was the first demonstration of 
efficient growth inhibition using this extract/bacterial combination.  There was no visible 
inhibition of the other bacterial species, with the exception of Pseudomonas aeruginosa, 
which appeared to demonstrate some minor extract effects.  However, this effect failed to 
appear when investigated in additional trials (data not shown).   
 
 
Figure 6:  3
rd
 trial of S. aureus treated with A. tridentata methanol extract 
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Growth Inhibition and Combination with Antibiotics 
 Based upon these positive results, demonstrating Artemisia tridentata methanol 
extract growth inhibition of Staphylococcus aureus, additional methanol extracts were 
created from the same plant material.  Eventually, these were fractionated into hexane, 
ethyl acetate and water extracts, as will be described below, and the antibacterial 
efficacies of each assayed.  None showed growth inhibitory effects versus the other 
bacterial species investigated, acting only on Staphylococcus aureus (data not shown), 
with each extract demonstrating some efficacy against this species.  However, it was 
noted that there was some variation in the antibacterial assay results among the various 
methanol extracts, despite their having been originally derived from the same original 
plant material.  This discrepancy was likely attributable to variations in extraction yield.  
Therefore, for the sake of producing a set of consistent results for evaluation, the 
antibacterial trials described in the following pages were performed with an extract 
derived from a single sample of plant material.   
 43.6105 g of Artemisia tridentata dried plant leaves (buds and stems were 
excluded as much as possible) was ground with a mortar and pestle, and subjected to 
boiling in methanol with the use of a reflux condenser.  Approximately 258 ml of 
methanol was added to the plant material (≈ 6 ml solvent per g of plant material), and the 
mixture boiled for about 45 minutes.  The supernatant was decanted, an approximate 
equivalent volume of fresh methanol was added to the plant material, and the boiling 
process was repeated.  Each supernatant was independently filtered through cotton after 
boiling, and the pooled filtrates then passed through Whatman #1 filter paper.   
 
75 
 
 The resultant solution had a remaining volume of nearly 350 ml, with some 
methanol likely absorbed by the plant material or lost during the boiling process despite 
the use of a reflux condenser.  Using separatory funnels, this solution was fractionated 
into hexane using an approximately equivalent volume, with an additional 50 ml hexane 
added during the process to enhance visible separation of the solvents.  The hexane 
portion was filtered through Whatman #1 filter paper to remove visible particulate matter, 
dried using rotary evaporation, and desiccated under vacuum.  The methanol portion was 
also dried using these methods. 
 The dried methanol extract was eventually re-suspended in ethyl acetate, and this 
solution fractionated with deionized water.  Approximate volumes of 300 ml of ethyl 
acetate and 240 ml of water were necessary to achieve visible separation of the solvents 
and avoid saturation of either.  Interestingly, overnight storage of the fractions at 4°C 
resulted in further separation of ethyl acetate in the water portion, suggesting that the 
fractionation of these two solvents might be enhanced in the future through the use of 
longer wait times.  In addition to the top layer of immiscible ethyl acetate, there was also 
a middle layer visible between this and the aqueous layer, appearing to consist of fat 
micelles.  Both of these top two layers were removed, and the remaining water portion 
filtered through Whatman #1 filter paper.  The original ethyl acetate portion also had 
some visible fat micelles, though an attempt to remove these by means of paper filtration 
was unsuccessful.  This ethyl acetate mixture was dried in a manner similar to the 
methanol and hexane solutions, while the water portion required freeze drying to remove 
the solvent.  All dried extracts were suspended in DMSO to a concentration of 100 µg/ml.  
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 The antibacterial assays testing these extracts were performed in 96-well plates. 
Prior to inoculation, all wells contained a final volume of 100 µl.  Overnight cultures of 
Staphylococcus aureus were routinely grown at approximately 37°C and 225 rpm for a 
length of 16-17 hours, as it was observed from the results of earlier experiments that 
harvesting the cultures during this time frame resulted in better growth of untreated 
bacterial controls in the assays, thereby enhancing detection of antibacterial effects.  The 
following day, the cultures were diluted to an OD600 reading between 0.950-1.050, and 2 
µl culture added to the appropriate wells.  Again using the Escherichia coli optical 
density standard for numeration, this should have resulted in approximate cell counts of 
1.52-1.68 x 10
7
 cells/ml ([8 x 10
8
 cell/ml x 0.002]/ 0.1 ml), less than the inoculum level 
used in the screenings of the other plant species described above, but still considerably 
greater than those used in the aforementioned 1967 study.   
Untreated LB samples served as sterility controls, untreated Staphylococcus 
aureus samples were used as negative controls, and samples treated with 25 µg/ml 
tetracycline served as positive controls.  DMSO vehicle controls were no longer included 
due to a lack of available space on the plates, and the fact that the highest concentration 
of extract assayed required the addition of a lower volume than that of DMSO deemed to 
have no inhibitory effects when tested in prior assays.  In each assay, the extract to be 
tested was diluted from stock to concentrations of 500, 250, 125, 62.5 and 31.25 µg/ml in 
100 µl LB.  Also in each assay, one of three antibiotics:  ampicillin, amikacin or G418 
sulfate, was diluted in LB to a series of concentrations previously determined to possess 
intermediate antibacterial efficacy versus Staphylococcus aureus under similar assay 
conditions (data not shown).   
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Each extract concentration and each antibiotic concentration was tested 
independently, as was each possible extract/antibiotic combination.  All samples, 
including controls, were prepared in triplicate, and each assay was run in triplicate.  
Averaged initial OD600 values, following sample treatment and bacterial inoculation, but 
prior to incubation, were subtracted from all subsequent readings to account for 
background absorbance of the media, antibiotics and extracts.  Negative values were 
considered as readings of zero.  Plates were incubated at approximately 37°C and 125 
rpm, with additional OD600 measurements taken at 1-hour intervals for 6 hours using a 
PowerWave XS Microplate Spectrophotometer (Bio-Tek).  The averaged results from 
each of the three assays were then combined and averaged together.  Statistical analysis 
was performed on the 6-hour time point values using an unpaired t-test assuming equal 
variances.  P values of less than 0.05 were considered statistically significant.   
The first set of assays tested the hexane extract, alone and in combination with the 
antibiotic G418 sulfate.  As can be seen in figure 7, the extract at a concentration of 500 
µg/ml demonstrated significant antibacterial efficacy through 6 hours, with a growth 
curve similar to that of the positive control, while a concentration of 250 µg/ml also 
resulted in moderate, but significant growth inhibition.  The growth curves of the samples 
treated at lower extract concentrations more closely resembled those of the untreated 
control, with no statistically significant bacterial inhibition.   
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Figure 7:  S. aureus treated with A. tridentata hexane extract 
 
As can be seen in figure 8, G418 sulfate demonstrated strong antibacterial 
efficacy at a concentration of 10 µg/ml, with moderate effects seen at the 5 µg/ml level, 
and mild effects at a concentration of 2.5 µg/ml, with all results statistically significant.  
G418 sulfate at a concentration of 1.25 µg/ml failed to significantly inhibit bacterial 
growth. 
 
 
Figure 8:  S. aureus treated with G418 sulfate 
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As can be seen in figures 9-13, the combination of hexane extract with G418 
sulfate enhanced growth inhibition.  At a G418 sulfate concentration of 1.25 µg/ml for 
example, growth inhibition became significant in comparison to the untreated control 
when combined with extract concentrations of 62.5 µg/ml and greater, and in comparison 
to the antibiotic alone at this concentration when combined with extract levels of 
125µg/ml and greater. 
 
 
Figure 9:  S. aureus treated with G418 sulfate and hexane extract (500 µg/ml) 
 
 
 
 
Figure 10:  S. aureus treated with G418 sulfate and hexane extract (250 µg/ml) 
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Figure 11:  S. aureus treated with G418 sulfate and hexane extract (125 µg/ml) 
 
 
 
 
 
 
 
Figure 12:  S. aureus treated with G418 sulfate and hexane extract (62.5 µg/ml)   
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Figure 13:  S. aureus treated with G418 sulfate and hexane extract (31.25 µg/ml)   
 
The next set of assays tested the hexane extract alone and in combination with the 
antibiotic amikacin.  As can be seen in figure 14, the results for the hexane extract alone 
were very similar to those of the G418 sulfate combinatorial assays, with significant 
antibacterial effects only at concentrations of 250 and 500 µg/ml.  Amikacin 
demonstrated strong efficacy at concentrations of 10 and 5 µg/ml, with lesser, but still 
statistically significant growth inhibition at a concentration of 2.5 µg/ml (figure 15).  
  
 
Figure 14:  S. aureus treated with A. tridentata hexane extract 
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Figure 15:  S. aureus treated with amikacin 
 
In combination (figures 16-20), the efficacy of growth inhibition was again 
visibly improved.  Growth inhibition by amikacin at a concentration of 1.25 µg/ml 
became statistically significant compared to the untreated control when combined with 
extract at concentrations of 62.5 µg/ml and greater, and in comparison to the antibiotic 
alone at this concentration at extract levels of 125µg/ml and greater. 
 
 
Figure 16:  S. aureus treated with amikacin and hexane extract (500 µg/ml) 
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Figure 17:  S. aureus treated with amikacin and hexane extract (250 µg/ml) 
 
 
 
 
 
 
 
Figure 18:  S. aureus treated with amikacin and hexane extract (125 µg/ml) 
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Figure 19:  S. aureus treated with amikacin and hexane extract (62.5 µg/ml) 
 
 
 
 
Figure 20:  S. aureus treated with amikacin and hexane extract (31.25 µg/ml)   
 
The next set of assays tested the hexane extract alone and in combination with the 
antibiotic ampicillin.  As can be seen in figure 21, the results for the hexane extract alone 
were very similar to those of the previous assays, though inhibition at the concentration 
of 125 µg/ml was also statistically significant in these assays.  Growth inhibition by 
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ampicillin (figure 22), though not comparable to the positive control, was statistically 
significant at all concentrations tested.   
 
 
Figure 21:  S. aureus treated with A. tridentata hexane extract   
 
 
 
 
Figure 22:  S. aureus treated with ampicillin 
 
 
In combination (figures 23-27), antibacterial efficacy was again enhanced.  The 
lower concentrations of 0.625 and 1.25 µg/ml for example, showed significantly 
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improved efficacy in comparison to their individual performances when combined with 
extract levels of 125 µg/ml or greater.    
 
 
 
Figure 23:  S. aureus treated with ampicillin and hexane extract (500 µg/ml) 
 
 
 
 
 
Figure 24:  S. aureus treated with ampicillin and hexane extract (250 µg/ml) 
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Figure 25:  S. aureus treated with ampicillin and hexane extract (125 µg/ml)   
 
 
 
 
 
 
 
Figure 26:  S. aureus treated with ampicillin and hexane extract (62.5 µg/ml)   
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Figure 27:  S. aureus treated with ampicillin and hexane extract (31.25 µg/ml)   
 
The ethyl acetate extract was the next to be assayed in combination with these 
antibiotics, beginning with G418 sulfate.  As can be seen in figure 28, the ethyl acetate 
extract alone displayed stronger antibacterial efficacy than did the hexane extract, with 
statistically significant growth inhibition at concentrations as low as 62.5 µg/ml.  G418 
sulfate performed as it did before (figure 29), with significant inhibition at levels of 2.5 
µg/ml and greater.  
 
 
Figure 28:  S. aureus treated with A. tridentata ethyl acetate extract 
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Figure 29:  S. aureus treated with G418 sulfate 
 
In combination (figures 30-34), G418 sulfate at a concentration of 1.25 µg/ml, 
which alone was ineffective, exhibited significant growth inhibition in comparison to 
both the untreated control and the antibiotic alone at this level with extract concentrations 
as low as 62.5 µg/ml.  This combinatorial effect in comparison to the antibiotic alone is 
greater than that observed with the hexane extract and G418 sulfate. 
 
 
Figure 30:  S. aureus treated with G418 sulfate and ethyl acetate extract (500 µg/ml) 
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Figure 31:  S. aureus treated with G418 sulfate and ethyl acetate extract (250 µg/ml) 
 
 
 
 
 
 
 
Figure 32:  S. aureus treated with G418 sulfate and ethyl acetate extract (125 µg/ml) 
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Figure 33:   S. aureus treated with G418 sulfate and ethyl acetate extract (62.5 µg/ml)  
 
 
 
 
Figure 34:  S. aureus treated with G418 sulfate and ethyl acetate extract (31.25 µg/ml)   
 
When tested alone (figures 35 and 36), both the ethyl acetate extract and amikacin 
performed as they had done previously, with significant inhibition seen at concentrations 
as low as 62.5 µg/ml by the extract, and at levels as low as 2.5 µg/ml for the antibiotic.   
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Figure 35:  S. aureus treated with A. tridentata ethyl acetate extract 
 
 
 
 
Figure 36:  S. aureus treated with amikacin   
 
At 1.25 µg/ml amikacin, growth inhibition became statistically significant in 
comparison to both the untreated control and the antibiotic alone at this level with extract 
concentrations of 62.5 µg/ml or greater (figures 37-41).  Again, this combinatorial effect 
in comparison to the antibiotic alone was greater than that observed for amikacin with the 
hexane extract. 
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Figure 37:  S. aureus treated with amikacin and ethyl acetate extract (500 µg/ml)  
 
 
 
 
 
 
 
Figure 38:  S. aureus treated with amikacin and ethyl acetate extract (250 µg/ml) 
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Figure 39:  S. aureus treated with amikacin and ethyl acetate extract (125 µg/ml)   
 
 
 
 
 
 
 
Figure 40:  S. aureus treated with amikacin and ethyl acetate extract (62.5 µg/ml)   
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Figure 41:  S. aureus treated with amikacin and ethyl acetate extract (31.25 µg/ml)  
  
When tested with ampicillin, the ethyl acetate extract (figure 42) again performed 
as before, with significant inhibition at concentrations as low as 62.5 µg/ml, while the 
antibiotic (figure 43) again displayed significant antibacterial effects at all concentrations 
tested.   
 
 
Figure 42:  S. aureus treated with A. tridentata ethyl acetate extract 
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Figure 43:  S. aureus treated with ampicillin 
 
Interestingly, though also demonstrating enhanced growth inhibition, the 
combinatorial effects observed for the ethyl acetate extract with ampicillin were less 
pronounced than they were for the hexane extract with this antibiotic, despite the 
seemingly superior growth inhibition of the ethyl acetate extract alone (figures 44-48).  
At the lower ampicillin concentrations of 0.625 and 1.25 µg/ml, improved efficacy was 
only significant in comparison to the antibiotic alone at these levels with extract 
concentrations of 250 and 500 µg/ml. 
 
 
Figure 44:  S. aureus treated with ampicillin and ethyl acetate extract (500 µg/ml) 
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Figure 45:  S. aureus treated with ampicillin and ethyl acetate extract (250 µg/ml) 
 
 
 
 
 
 
 
Figure 46:  S. aureus treated with ampicillin and ethyl acetate extract (125 µg/ml) 
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Figure 47:  S. aureus treated with ampicillin and ethyl acetate extract (62.5 µg/ml) 
 
 
 
 
Figure 48:  S. aureus treated with ampicillin and ethyl acetate extract (31.25 µg/ml) 
 
Finally, the antibiotics were tested alone and in combination with the water 
extract.  As can be seen in figure 49, the water extract alone demonstrated lesser 
antibacterial efficacy than did the other two extracts, with significant inhibition observed 
only at a concentration of 500 µg/ml.  The antibiotic G418 sulfate (figure 50) alone 
performed in a manner similar to that observed in the preceding assays, yet with 
statistically significant inhibition seen only at concentrations of 5 and 10 µg/ml. 
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Figure 49:  S. aureus treated with A. tridentata water extract 
 
 
 
 
Figure 50:  S. aureus treated with G418 sulfate  
 
In combination (figures 51-55), G418 sulfate at the concentration of 1.25 µg/ml 
displayed significant growth inhibition in comparison to the untreated control only at 
extract levels of 250 and 500 µg/ml, and in comparison to the antibiotic alone at this level 
only at an extract concentration of 500 µg/ml.  Both of these combinatorial effect 
comparisons were the weakest among the three extracts. 
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Figure 51:  S. aureus treated with G418 sulfate and water extract (500 µg/ml) 
 
 
 
 
 
 
 
Figure 52:  S. aureus treated with G418 sulfate and water extract (250 µg/ml)   
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Figure 53:  S. aureus treated with G418 sulfate and water extract (125 µg/ml) 
 
 
 
 
 
 
 
Figure 54:  S. aureus treated with G418 sulfate and water extract (62.5 µg/ml) 
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Figure 55:  S. aureus treated with G418 sulfate and water extract (31.25 µg/ml) 
 
 
 
When tested with amikacin, the water extract alone (figure 56) performed slightly 
better, with significant growth inhibition seen at both 250 and 500 µg/ml.  Amikacin 
performance was similar to previous assays (figure 57), though in this case inhibition at 
the 1.25 µg/ml level was statistically significant.   
 
 
Figure 56:  S. aureus treated with A. tridentata water extract 
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Figure 57:  S. aureus treated with amikacin 
 
In combination (figures 58-62), inhibition by amikacin at a concentration of 1.25 
µg/ml became significant in comparison to the antibiotic alone at this level with extract 
levels of 125 µg/ml and greater.  This level of enhancement is similar to that observed for 
amikacin with the hexane extract, though still less than that seen when this antibiotic was 
combined with the ethyl acetate extract.   
 
 
Figure 58:  S. aureus treated with amikacin and water extract (500 µg/ml) 
104 
 
 
 
 
 
 
 
 
Figure 59:  S. aureus treated with amikacin and water extract (250 µg/ml)   
 
 
 
 
 
 
 
Figure 60:  S. aureus treated with amikacin and water extract (125 µg/ml)   
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Figure 61:  S. aureus treated with amikacin and water extract (62.5 µg/ml) 
 
 
 
 
Figure 62:  S. aureus treated with amikacin and water extract (31.25 µg/ml) 
 
Finally, when tested with ampicillin, the water extract alone (figure 63) again 
showed significant inhibition only at concentrations of 250 and 500 µg/ml, while the 
antibiotic (figure 64) once again showed some inhibition at all concentrations tested, 
though in this case the effect was not significant at a concentration of 0.625 µg/ml.    
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Figure 63:  S. aureus treated with A. tridentata water extract 
 
 
 
 
Figure 64:  S. aureus treated with ampicillin 
 
In combination (figures 65-69), inhibition by ampicillin at 0.625 µg/ml became 
significant in comparison to the untreated control with extract levels of 62.5 µg/ml and 
greater.  However, improved growth inhibition by ampicillin both at this concentration 
and at 1.25 µg/ml became significant in comparison to these antibiotic concentrations 
alone only when combined with extract levels of 250 or 500 µg/ml.  This latter result is 
similar to that observed for the combination of ampicillin with the ethyl acetate extract, 
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both of which were weaker than the results demonstrated by the antibiotic in combination 
with the hexane extract.  
 
 
Figure 65:  S. aureus treated with ampicillin and water extract (500 µg/ml) 
 
 
 
 
Figure 66:  S. aureus treated with ampicillin and water extract (250 µg/ml) 
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Figure 67:  S. aureus treated with ampicillin and water extract (125 µg/ml) 
 
 
 
 
 
 
 
Figure 68:  S. aureus treated with ampicillin and water extract (62.5 µg/ml) 
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Figure 69:  S. aureus treated with ampicillin and water extract (31.25 µg/ml) 
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Time-Extended Assays   
Using selected concentrations of the extracts and antibiotics, further assays were 
performed to approximate the length of time over which the Artemisia tridentata extracts 
were capable of enhancing the antibacterial efficacy of the antibiotics ampicillin, 
amikacin and G418 sulfate versus Staphylococcus aureus.  The experimental conditions 
were identical to those used in the immediately above described antibacterial assays.  
Each of the extracts was tested alone at a concentration of 500 µg/ml.  Each of the 
antibiotics was tested alone at concentrations of 5 and 2.5 µg/ml, as these levels, when 
used in the previous assays, demonstrated both intermediate bacterial growth inhibitory 
efficacy by themselves, as well as improved performance when combined with the 
extracts.  Finally, each antibiotic at each of these two concentrations was tested in 
combination with each extract (500 µg/ml).  OD600 measurements were taken 
immediately following sample treatment and bacterial inoculation, and at hourly time 
points for twelve hours.  Again, the averaged results from each of the three assays were 
then combined and averaged together.  Statistical analysis was performed on the 12-hour 
time point values using an unpaired t-test assuming equal variances.  P values of less than 
0.05 were considered statistically significant.  
As can be seen in figures 70 and 71 below, among the three extracts when tested 
alone, the hexane extract appears to have demonstrated the strongest antibacterial 
efficacy through six hours, a result consistent with previous assays at the extract 
concentration of 500 µg/ml.  The hexane and ethyl acetate extracts continued to display 
statistically significant growth inhibition through twelve hours in comparison to the 
untreated control, though these effects were minimal.  Among the antibiotics when tested 
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alone, ampicillin at both concentrations and amikacin at the concentration of 5 µg/ml 
appear to have demonstrated intermediate growth inhibition at the 6-hour time point.  
However, only amikacin continued to demonstrate statistically significant growth 
inhibition through twelve hours.  The efficacy of the extracts and antibiotics in these 
assays were possibly lessened by more virulent growth of the bacteria, as the untreated 
controls demonstrated slightly greater OD600 levels after six hours in comparison to 
previous assays. 
 
 
 
Figure 70:  S. aureus treated with A. tridentata extracts 
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Figure 71:  S. aureus treated with G418 sulfate, amikacin, ampicillin 
 
Still, in combination, as can be seen in figures 72-74, antibacterial efficacy was 
again improved.  G418 sulfate growth inhibition at the 12-hour time point became 
statistically significant in comparison to the untreated control when combined with each 
extract, with the growth curves of samples treated with G418 sulfate and either the 
hexane or ethyl acetate extracts resembling that of the positive control.  Enhancement of 
growth inhibition by all extracts was also statistically significant in comparison to the 
antibiotic alone at both concentrations. 
Similarly, the growth curves of samples treated with amikacin at 5 µg/ml, in 
combination with either the hexane or ethyl acetate extracts, resembled that of the 
positive control, with the enhancement of growth inhibition statistically significant in 
comparison to the antibiotic alone at this concentration.  However, the water extract 
significantly reduced the efficacy of amikacin at 5 µg/ml.  At 2.5 µg/ml, growth 
inhibition by amikacin became significant in comparison to the untreated control when 
combined with the hexane or ethyl acetate extracts, but not the water extract, again with 
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the growth curves of samples treated with combinations of amikacin and the hexane or 
ethyl acetate extracts resembling that of the positive control.  While the enhancement of 
growth inhibition by the combination of amikacin at 2.5 µg/ml with all of the extracts 
was statistically significant in comparison to the antibiotic alone at this concentration, it 
can be seen that the effect of the water extract was minimal.   
  Extract enhancement of growth inhibition by ampicillin was less pronounced.  
At 5 µg/ml, growth inhibition in comparison to the untreated control only became 
statistically significant when ampicillin was combined with the hexane extract.  Though 
enhancement of growth inhibition by all extracts was statistically significant in 
comparison to ampicillin alone at this concentration, this is attributable to the high final 
OD600 level of the ampicillin-treated sample, and it can be seen from the figure that only 
the hexane extract noticeably improved antibiotic efficacy.   At 2.5 µg/ml, similar results 
were observed, with only the hexane extract significantly improving the efficacy of 
amikacin in comparison to the untreated control, or the antibiotic alone at this 
concentration.   
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Figure 72:  S. aureus treated with G418 sulfate and A. tridentata extracts 
 
 
 
 
 
 
 
Figure 73:  S. aureus treated with amikacin and A. tridentata extracts 
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Figure 74:  S. aureus treated with ampicillin and A. tridentata extracts 
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Extracts in Combination 
 The extracts were also assayed in combination with each other to observe for any 
negating or enhancement of antibacterial efficacy which might indicate the presence of 
antagonistic, additive or synergistic compounds present in the original plant material.  
Experimental conditions were the same as those described above.  Each extract was 
tested alone at concentrations of 500, 250, 125 and 62.5 µg/ml, and in combination at 
concentrations of 250, 125, 62.5 and 31.25 µg/ml. 
 As can be seen in figures 75-77, the performances of the extracts alone were 
similar to those observed in previous assays, with statistically significant growth 
inhibition observed at all hexane and ethyl acetate extract concentrations, and at water 
extract concentrations of 500 and 250 µg/ml. 
 
 
Figure 75:  S. aureus treated with A. tridentata hexane extract 
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Figure 76:   S. aureus treated with A. tridentata ethyl acetate extract 
 
 
 
 
Figure 77:   S. aureus treated with A. tridentata water extract  
 
Using the same method of statistical analysis, the OD600 values measured at the 6-
hour time point for each pairing of extracts was compared to the average of the values of 
each extract alone at the total extract concentration.  For example, the final reading for 
the combination of the ethyl acetate and hexane extracts (figure 78) at 250 µg/ml each 
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was compared to the average between the final readings for the ethyl acetate and hexane 
extracts alone when tested at 500 µg/ml.  Though the dose-response relationships 
between the extracts and growth inhibition in these or previous assays do not appear to 
have demonstrated perfectly linear correlations, it would be reasonable to expect that 
dramatic antagonistic, additive or synergistic effects between extracts might result in 
observable effects on the growth curves of treated samples.  In the case of the hexane and 
ethyl acetate extracts, this combination showed significant inhibition versus the untreated 
control only at concentrations of 125 and 250 µg/ml each, with statistically significant 
diminishment of antibacterial efficacy in comparison to the averages of the extracts alone 
at all concentrations tested.   
 
 
Figure 78:  S. aureus treated with A. tridentata hexane and ethyl acetate extracts 
 
The hexane and water extracts in combination also demonstrated significant 
growth inhibition at concentrations of 125 and 250 µg/ml each (figure 79).  While the 
readings for this extract pairing at lesser concentrations were significantly larger than the 
average values from each extract alone, at 250 µg/ml each, diminishment was minimal.   
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Figure 79: S. aureus treated with A. tridentata hexane and water extracts  
 
 Finally, in the case of the combination of the ethyl acetate and water extracts 
(figure 80), significant inhibition in comparison to the untreated control was observed at 
concentrations of 62.5 µg/ml and greater.  Though there was a slight but statistically 
significant diminishment of antibacterial efficacy at extract concentrations of 250 µg/ml 
each in comparison to the averaged values of each extract at 500 µg/ml, lower 
combinatorial values were similar to what was anticipated. 
 
 
Figure 80:  S. aureus treated with A. tridentata ethyl acetate and water extracts 
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Ampicillin-Resistant Staphylococcus aureus 
 To determine if these extracts also possess growth inhibitory efficacy alone and/or 
in combination with a synthetic antibiotic versus a drug-resistant strain of Staphylococcus 
aureus, antibacterial assays were conducted using SA-BAA-44, an ampicillin-resistant 
strain of this bacterial species.  Experimental conditions were similar to those described 
above for the previous extract/antibiotic combinatorial assays.  However, extracts were 
only tested alone at concentrations of 500, 250, 125 and 62.5 µg/ml, with the previously 
used lowest extract concentration of 31.25 µg/ml excluded.  Also, ampicillin was tested 
alone at considerably higher concentrations of 800, 400, 200 and 100 µg/ml, as these 
levels were determined in a separate experiment as necessary to demonstrate intermediate 
growth inhibitory effects (data not shown).  Each extract, at a concentration of 500 µg/ml, 
was also tested in combination with each concentration of ampicillin.  The method of 
statistical analysis employed, using the 6-hour time point readings, remained the same. 
 As can be seen in the following figures, growth of the untreated BAA-44 strain 
was substantially less than that of the antibiotic-susceptible strain, despite identical 
culture conditions.  The hexane extract appears to have retained some inhibitory efficacy 
(figure 81), though this was only statistically significant at a concentration of 500 µg/ml.  
The ethyl acetate extract (figure 82) was also only significantly effective at the maximum 
concentration assayed.  The water extract (figure 83) demonstrated no significant 
antibacterial efficacy at any concentration.  
121 
 
 
 
 
 
 
 
 
Figure 81:  S. aureus BAA-44 treated with hexane extract 
 
 
 
 
 
 
 
Figure 82:  S. aureus BAA-44 treated with ethyl acetate extract 
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Figure 83:  S. aureus BAA-44 treated with water extract 
 
 Ampicillin alone (figure 84) demonstrated statistically significant efficacy versus 
strain BAA-44 only at a concentration of 800 µg/ml.  However, in combination with the 
hexane extract at a concentration of 500 µg/ml (figure 85), growth inhibition became 
significant in comparison to both the untreated control and each ampicillin concentration 
alone, with growth curves resembling those of the positive control.  In combination with 
the ethyl acetate extract (figure 86), growth inhibition again became statistically 
significant at all antibiotic concentrations using these comparisons, though the flattening 
of the growth curves of treated samples was less impressive than that of the hexane 
extract/antibiotic combinatorial samples.  The water extract, by contrast, failed to 
demonstrate any statistically significant enhancement of antibiotic efficacy (figure 87). 
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Figure 84:  S. aureus BAA-44 treated with ampicillin   
 
 
 
 
 
 
 
Figure 85:  S. aureus BAA-44 treated with ampicillin and hexane extract  
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Figure 86: S. aureus BAA-44 treated with ampicillin and ethyl acetate extract  
 
 
 
 
 
 
 
Figure 87:  S. aureus BAA-44 treated with ampicillin and water extract  
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Biofilm Formation Assays 
In order to explore their potential in preventing Staphylococcus aureus biofilm 
formation on solid surfaces, the Artemisia tridentata extracts (hexane, ethyl acetate, 
water) were assayed for this ability using COSTAR brand 96-well polystyrene plates.  All 
wells contained a final volume of 100 µl prior to inoculation, and all sample types were 
prepared in triplicate.  Two sets of wells were excluded from inoculation, and contained 
only LB.  The first served to ensure sterility of the media and the plate, while the second 
served as a background control, measuring stain binding to the plate in the absence of a 
biofilm.  Each extract was tested at concentrations of 500, 250 and 125 µg/ml in LB.  
DMSO in LB at 0.5% matched the dilution level of the highest extract concentration, and 
served as a vehicle control.  Untreated samples served as a negative control, while 3% 
Nonidet P40 in LB served as a positive control.  Overnight cultures of Staphylococcus 
aureus were diluted to OD600 levels of between 0.950 and 1.050, as in previous assays.  
However, 5 µl of this diluted culture was added to the appropriate wells on the plate, as 2 
µl inoculums failed to demonstrate consistent biofilm formation in the untreated control 
samples in a previous assay (data not shown).         
As the experimental design did not cause more than half the wells in the plate to 
be occupied, the setup was repeated a second time on the lower half of the plate, with the 
exception of the sterility control wells and the background stain binding control wells, 
thus providing two sets of samples in the event that one failed.  The plate was incubated 
without rotation for approximately 10 hours at about 37°C.  Spectrophotometric readings 
of the plate were taken at 600 nm before and after incubation to detect media or plate 
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contamination in the sterility control wells.  Following incubation, the plate contents were 
decanted, and the plate rinsed three times in water.  100 µl of a 0.1% crystal violet 
solution was added to the wells, and the plate incubated at room temperature for about 15 
min.  The plate contents were again decanted, the plate rinsed seven times in water, and 
the wells allowed to air-dry overnight in an open environment.  
The following day, 100 µl of a 95% ethanol solution was added to all of the wells 
except the sterility control wells, and a spectrophotometric measurement was taken at 595 
nm to measure crystal violet retention.  The averaged readings from the background stain 
binding control wells were subtracted from the values of the other samples, with negative 
numbers considered as readings of zero.  The results from the six sets of samples are 
averaged in table 2 below, where it can be seen that none of the extracts demonstrated 
inhibition of Staphylococcus aureus biofilm formation under these experimental 
conditions.  In fact, the extract-treated wells routinely retained more stain than did the 
untreated controls and DMSO-treated samples, with several results excluded due to 
readings too high to be accurately measured by the spectrophotometer.   
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Table 2:  Biofilm formation assay results 
Starting 
OD600
10Hr OD595
Untreated Average 0.100 1.326 1.232
Nonidet P40 3% solution Average 0.289 0.000 0.051
Staphylococcus aureus and 0.5% DMSO Average 0.106 1.358 1.363
Staphylococcus aureus and 500 ug/ml Hexane Extract Average 0.300 1.082 1.853
Staphylococcus aureus and 250 ug/ml Hexane Extract Average 0.197 1.247 1.953
Staphylococcus aureus and 125 ug/ml Hexane Extract Average 0.151 1.392 1.681
Staphylococcus aureus and 500 ug/ml Ethyl Acetate Extract Average 0.275 0.797 2.746
Staphylococcus aureus and 250 ug/ml Ethyl Acetate Extract Average 0.188 1.173 2.759
Staphylococcus aureus and 125 ug/ml Ethyl Acetate Extract Average 0.141 1.363 2.417
Staphylococcus aureus and 500 ug/ml Water Extract Average 0.131 0.870 2.601
Staphylococcus aureus and 250 ug/ml Water Extract Average 0.126 1.331 1.806
Staphylococcus aureus and 125 ug/ml Water Extract Average 0.119 1.476 1.714
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Static Biofilm Assays 
 Additional assays were performed to determine the antibacterial efficacy of the 
Artemisia tridentata extracts and the antibiotics ampicillin, amikacin or G418 sulfate, 
alone or in combination, versus static Staphylococcus aureus biofilms.  As in the biofilm 
formation assays, COSTAR brand polystyrene 96-well polystyrene plates were used, and 
sample types were prepared in triplicate.  100 µl LB was added to all wells of the plate to 
be used in the assay.  An overnight culture of Staphylococcus aureus was diluted in LB to 
an OD600 level between 0.950-1.050, and 5 µl of the diluted culture was added to all LB-
containing wells, excluding the first set of three.  The plate was then incubated without 
rotation at approximately 37°C for about 10 hours.  OD600 measurements of the first three 
wells, taken before and after incubation, served to ensure sterility of the media and the 
plate.   
 Following incubation, treatments were added to the static biofilms.  The sterility 
control wells, to which no bacteria was added, also served to measure background stain 
binding to the plate in the absence of a biofilm.  Therefore no treatment of these wells 
was necessary.  The second and third sets of wells served as negative controls.  To the 
second set of wells, nothing was added, while 100 µl fresh LB was added to the wells of 
the third set.   
As the extracts and antibiotics were to be added already pre-diluted to twice their 
desired final concentrations in 100µl volumes of LB, the purpose of this differential 
treatment of negative controls was to determine if leaving the untreated controls without 
an added 100µl fresh LB during the period of sample treatment would result in cell death.  
This could result in reduced biofilm stain binding, possibly masking extract or antibiotic 
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biofilm-removal effects.  Alternatively, adding 100 µl LB could result in additional 
growth of the biofilm during the sample treatment period, possibly overstating extract or 
antibiotic effects.  Therefore both possibilities needed to be explored.  Each extract and 
antibiotic, pre-diluted in LB, was added and tested alone at final concentrations of 500 
µg/ml and 1 mg/ml, respectively.   Each extract and antibiotic were also tested in 
combination.  Qiagen Lysis buffer, containing SDS and sodium hydroxide, served as a 
positive control.  Following sample treatment, the plate was returned to incubation under 
the same conditions for approximately twelve hours.    
The following day, the plate was washed and stained in a manner similar to the 
biofilm formation assays described above.  As can be seen in table 3 below, results for 
the untreated controls were relatively similar regardless of the addition of fresh LB 
during sample treatment.  However, none of the extracts or antibiotics by themselves, 
with the exception of ampicillin, demonstrated any reduction in stain retention in 
comparison to the untreated controls.  Also, in combination, only the water extract 
applied together with ampicillin demonstrated any biofilm reduction, but this result was 
almost identical to that of ampicillin alone.  Thus, the assay was abandoned after two 
repetitions.     
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Table 3:  Static biofilm assay results 
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Serial Dilution and Plating  
 In an effort to determine whether the Artemisia tridentata extract antibacterial 
effects observed in earlier assays were bactericidal or bacteriostatic in nature, samples of 
Staphylococcus aureus cultures were serially diluted and plated after extract treatment to 
perform viable cell counts.  Overnight cultures were first diluted to an OD600 level of 
approximately 1.000.  A 50 µl sample was removed and mixed with a 450 µl volume of 
LB for a 1:10 dilution.  50 µl of this mixture was removed and mixed in another 450 µl 
volume of LB, and the process repeated until a final 1 x 10
-6 
dilution was achieved.  The 
entirety of the last dilution was plated on an LB agar plate, and served as a measure of the 
number of Staphylococcus aureus cells represented by an OD600 measurement 
approximating 1.000.   
 To test extract antibacterial effects, 10 µl of the dilution of the overnight culture 
(OD600 level of approximately 1.000) was added to each of three tubes containing an 
Artemisia tridentata extract (hexane, ethyl acetate, water) at a concentration of 500 µg/ml 
in 500 µl volumes of LB, thus keeping consistent with the inoculum to media ratio used 
in the 96-well plate antibacterial assays (2 µl culture to 100 µl LB).  A fourth tube 
containing tetracycline at a concentration of 25 µg/ml, also in a 500 µl volume of LB, 
served as a positive control, while two untreated tubes containing only 500 µl LB each 
served as negative controls.  1 ml LB in a sixth tube was included as a sterility control.  
All tubes were incubated at approximately 37°C and 125 rpm.   
After about 25 min, the extract-treated samples, the tetracycline-treated sample 
and one of the untreated samples were removed from incubation.  This time point was 
chosen based on a previous assay which indicated the doubling time of Staphylococcus 
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aureus under these experimental conditions to be approximately 35 min (data not shown).  
The objective was to sample prior to the doubling time, so that diminished colony counts 
in the extract-treated samples in comparison to the untreated control could be reasonably 
attributed to either a bactericidal or bacteriostatic effect.  For example, if the extract-
treated samples showed reduced numbers of viable cells in comparison to the untreated 
controls, this would be indicative of a bactericidal effect, whereas if the extract effect was 
bacteriostatic in nature, the cell count would still hypothetically approximate or match 
that of the untreated control if the samples were taken before the doubling time.  
However, if the samples were taken after the doubling time, diminished counts in extract-
treated samples in comparison to the untreated controls could be attributed either to a 
bacteriostatic effect, or to the bactericidal killing of only a portion of the initial inoculum, 
with the remaining cells continuing to multiply.   
50 µl from each of the samples removed from incubation at this time point was 
serially diluted in the same manner as described above, to a final dilution level of 1 x 10
-
4
, with the last of each of these dilutions (500 µl) plated on LB agar plates.  After a total 
of 2 hours, the second untreated sample and the sterility control were removed from 
incubation, with the untreated sample similarly diluted to a final dilution of 1 x 10
-5
.  The 
last dilution (500 µl), as well as the sterility control (1 ml), were also plated on LB agar 
plates.  All plates were incubated overnight at approximately 37°C, and the colony 
forming units counted the next day.  The assay was repeated three times. 
The results are tabulated in table 4 below.  The colony counts for the extract-
treated samples appear to have approximated those of the untreated control after 25 min 
of incubation. 
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Table 4:  Serial and dilution of A. tridentata extract-treated S. aureus 
1st Assay 2nd Assay 3rd Assay Average
Overnight Culture 2.72 x 10
8
9.92 x 10
7
6.29 x 10
7
1.45 x 10
8
Untreated (25 min) 6.64 x 10
6
3.00 x 10
6
1.72 x 10
6
3.79 x 10
6
Tetracycline [25 µg/ml] 6.00 x 10
4
2.00 x 10
4
4.40 x 10
5
1.73 x 10
5
Hexane extract [500 µg/ml] 6.18 x 10
6
2.16 x 10
6
1.60 x 10
6
3.31 x 10
6
Ethyl acetate extract [500 µg/ml] 6.62 x 10
6
3.44 x 10
6
2.16 x 10
6
4.07 x 10
6
Water extract [500 µg/ml] 5.30 x 10
6
2.58 x 10
6
1.62 x 10
6
3.17 x 10
6
Untreated (2 hr) 4.68 x 10
7
2.44 x 10
7
1.28 x 10
7
2.80 x 10
7
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Toxicity Assay 
 To determine their potential toxicity to humans, a line of breast cancer cells 
(MDA-MB-231 ATCC-HTB-26) was treated with various concentrations of the 
Artemisia tridentata ethyl acetate extract.  Cell samples (5 x 10
5
) were cultured in 
Dulbecco’s modified Eagle’s medium (Fisher Scientific), containing 10% fetal bovine 
serum, 0.1 mg/mL streptomycin, 100 U/mL penicillin, and 0.25 μg/mL amphotericin B at 
37 °C in a humidified CO#-controlled (5%) incubator.  The samples were then treated 
with various concentrations of the extract (50, 100, 200, 400 or 600 ug/ml) for a period of 
24 hours.  Untreated samples served as negative controls, while DMSO-treated samples 
(0.1%) served as vehicle controls.  Following extract treatment, cells were washed with 
PBS, and 2 ml serum-free culture media containing 1 mg/ml of the tetrazolium salt [3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]  (Sigma-Aldrich) was added 
to each well.  After 4 hours, the media was discarded, and DMSO was added to dissolve 
MTT-derived formazan.  The level of formazan was quantified by measurement of 
absorbance at a wavelength of 550 nm.  The assay was performed in triplicate.   
The amount of formazan in extract-treated samples was calculated as a percentage 
of the formazan in the untreated controls.  As can be seen in figure 88, the percentage of 
viable cells, as indicated by conversion of the tetrazolium salt to formazan, decreased 
with increasing concentrations of the ethyl acetate extract, with concentrations of 400 and 
600 µg/ml reducing the level of formazan converted to less than 10% of that of the 
untreated control.  DMSO had little to no effect (data not shown). 
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Figure 88:  Artemisia tridentata ethyl acetate extract-treated MDA-MB-231 cells 
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pH Measurement  
The pH of extract-containing LB samples was measured to investigate the 
possibility that the antibacterial effects previously demonstrated were due to changes in 
media acidity or basicity.  Each of the three Artemisia tridentata extracts (hexane, ethyl 
acetate, water) was diluted to a concentration of 500 µg/ml in a 50 ml volume of LB, and 
the pH of each sample measured with a Mettler Toledo “SevenEasy” meter.  An 
equivalent volume of untreated LB from the same preparation was also tested to ensure 
the media used was in fact at or close to the expected value of pH 7.  The untreated LB 
provided a pH reading of 6.96.  The pH readings for the extract-containing samples were 
only slightly reduced, with measurements of 6.95, 6.91 and 6.90 for the hexane, ethyl 
acetate and water extracts, respectively.   
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Ethidium Bromide Assays 
Ethidium bromide binding assays, based on the work of MA Jabra-Rizk et al
111
, 
were performed to determine if the mechanism of action by which the extracts exert their 
antibacterial effect is through cell membrane disruption.  Bacterial cell membrane 
disruption should result in the increased intercalation of ethidium bromide to bacterial 
DNA in cells exposed to this compound.  As in the antibacterial assays, overnight 
cultures of Staphylococcus aureus were first diluted in LB to OD600 levels between 
0.950-1.050.  Several ml were centrifuged for 15 min @ 5k rpm, the supernatant 
removed, and the cells suspended in an equal volume of PBS.   
500 µl of this cell suspension was added to 500 µl PBS in each of six tubes.  
Three of these six tubes each contained one of the Artemisia tridentata extracts (hexane, 
ethyl acetate, water) at a concentration of 1 mg/ml, yielding a final concentration of 500 
µg/ml following the addition of the cell suspension.  The fourth tube contained DMSO at 
a concentration of 2%, yielding a 1% final concentration following the addition of the 
cell suspension, and served as a vehicle control.  A fifth tube containing only PBS served 
as a negative control, while the sixth contained the detergent Nonidet P40 at a 
concentration of 2%, yielding a 1% final concentration following the addition of the cell 
suspension, and served as a positive control.    
All samples were incubated at approximately 37°C and 125 rpm for about 30 min.  
5 µg ethidium bromide in an aqueous solution was then added to each, and the samples 
were allowed to incubate at room temperature for approximately 15 min.  Samples were 
then centrifuged for 15 min @ 5k rpm, after which the supernatants were removed, and 
the cell pellets washed in 1 ml PBS each.  The centrifugation step was repeated, the 
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supernatants were again removed, and each pellet was suspended in 3 ml PBS.  Samples 
were then measured in a spectrofluorometer at 510 nm excitation and 605 nm emission to 
detect ethidium bromide binding to DNA.  In an effort to account for possible differences 
in cell numbers, samples were then measured in a spectrophotometer at 600 nm to 
measure bacterial cell density.  The assay was repeated in triplicate.  As can be seen 
below in table 5, the spectrophotometer readings were used to adjust the emission 
measurements of each treated sample to that of the untreated control based on cell 
density, and a ratio of the emission of the sample to that of the untreated control was then 
calculated for each.  Ethidium bromide binding to DNA was noticeably enhanced in the 
extract-treated samples, both in comparison to the negative control and the Nonidet P40-
treated positive control, with DMSO appearing to have little effect. 
 
 
Table 5:  Ethidium bromide binding assay results 
Emission OD600
Adjusted 
Value
Ratio
Untreated 23.490 0.062 NA NA
1 % Nonidet P-40 106.783 0.121 55.520 2.286
DMSO 14.697 0.049 20.205 0.888
Hexane extract 211.633 0.137 93.610 3.950
Ethyl acetate extract 228.412 0.126 112.913 4.670
Water extract 49.013 0.116 25.412 1.148
139 
 
DNA-nicking Assays 
 In order to determine if the antibacterial effect of these extracts is the result of a 
mechanism of action involving DNA damage, a DNA-nicking assay was performed to 
observe for strand cleavage using a construct variant of plasmid pGEX.  Plasmid DNA 
purified from bacteria is typically in its native supercoiled state.  DNA strand damage 
results in a loss of supercoiling, which causes a slower migration of the plasmid when 
compared to the supercoiled form in an electrophoretic gel.   
Five samples were prepared for each assay.  To each sample, 2 µl Fisher 
OPTIZYME™ 10X Buffer #5 (10 mM Tris-HCl, pH 8.5, 10 mM MgCl2, 100 mM KCl, 
0.1 mg/ml BSA) and 1 µl plasmid were added.  To three of the samples, an Artemisia 
tridentata extract (hexane, ethyl acetate, water) was added to a final concentration of 500 
µg/ml.  The fourth sample contained untreated plasmid and served as a negative control.  
To the fifth was added Fenton’s reagent (10 mM ferrous ammonium sulfate, 10 mM 
disodium EDTA, 9 mM hydrogen peroxide final concentrations)
112
, which served as a 
positive control.  All samples contained a total of 20 µl, with DI water constituting the 
remaining volume in each.     
 Samples were incubated in a water bath at about 37°C.  After approximately 10 
minutes, the positive control was removed and packed in ice.  After a total incubation 
time of approximately 60 minutes, the remaining samples were removed, and 6 µl of 4X 
loading dye was added to all samples.  The entirety of each sample was loaded into the 
wells of a 1 % agarose gel in 1X TAE buffer, and the gel run at 100 V for 90 minutes.  
The gel was stained with 30 µg ethidium bromide in 50 ml water for approximately 30 
minutes, and photographed.  The assay was repeated in triplicate.  As can be seen in 
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figures 89-91 below, treatment with the extracts did not appear to damage the DNA 
strands of the plasmid under the conditions assayed.  From right to left, the lanes 
represent the DNA ladder (λ-DNA-HindIII/φX-HaeIII), the untreated control, the 
Fenton’s reagent-treated positive control, the hexane extract, ethyl acetate extract and 
water extract-treated samples.  Band analysis performed using ImageJ software 
confirmed these negative results. 
 
 
 
Figure 89:  Gel electrophoresis of extract-treated pGEX (1
st
 assay) 
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Figure 90:  Gel electrophoresis of extract-treated pGEX (2nd assay) 
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Figure 91:  Gel electrophoresis of extract-treated pGEX (3rd assay) 
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Transmission Electron Microscopy 
Six 1 ml samples of the ethyl acetate and water Artemisia tridentata extracts in 
LB were prepared, each at a final concentration of 500 µg/ml.  An overnight culture of 
Staphylococcus aureus was diluted to an OD600 reading approximating 1.000, and 20 µl 
of this was added to each extract-containing tube.  The samples were then incubated for 
approximately 1 hour at about 37° C and 125 rpm.  Following incubation, the tubes were 
centrifuged for 10 min at 8k rpm, the supernatants were removed, and the resultant pellets 
for each extract treatment were pooled and washed in 1 ml PBS.  The centrifugation was 
repeated a second time, and following removal of the supernatants, each pellet was fixed 
with 500 µl 2.5 % glutaraldehyde in PBS, and stored at 4°C.  Cells added to six tubes 
containing LB without extract underwent the same treatment, and served as a negative 
control.       
A separate procedure was used for the hexane extract, as treated cells repeatedly 
failed to form an observable pellet using this protocol.  In this case, 200 µl cells were 
added to an extract-containing tube.  The cells were washed five times with fresh LB, 
then fixed with 1ml 2.5% glutaraldehyde in phosphate buffer at 4°C for 1 h.  The cells 
were then washed three more times using phosphate buffer.   
Prior to transmission electron microscopy (TEM), all samples were fixed with 1% 
osmium tetroxide for a period of 2 hours.  This was followed by three 10 minute 
washings with phosphate buffer, and subsequent dehydration in a series of ethanol 
concentrations (30%, 50%, 70%, 90% and 95%), for 15 min each.  Osmified tissues were 
dehydrated in a 95% ethanol/5% acetone solution, followed by absolute acetone, and 
embedded in epoxy resin (Epon 812, Pelco—EEUU).  Samples were then infiltrated and 
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embedded in Spurr’s resin (Epon 812, Pelco—EEUU).  Ultrathin sections were cut with a 
diamond knife using an ultramicrotome (Ultracut equipment -Leitz), and then mounted 
on bare copper grids.  Finally, specimens were counter stained with a 2% (w/v) uranyl 
acetate and lead citrate solution for 3 minutes, then with a 0.25% (w/v) solution for 2 
minutes, and examined with a Zeiss EM 900 microscopy (Zeiss, Oberkochen, Germany). 
As can be seen in figure 92 below, transmission electron microscopy of the 
untreated control demonstrated intact cell walls and membranes.  A similar result was 
observed for the water extract-treated cells (figure 93).  However, after treatment with 
either the hexane (figure 94) or ethyl acetate (figure 95) extracts, Staphylococcus aureus 
cells showed an apparent absence of cytoplasmic contents and unique chromatin 
organization (i.e., non-condensed chromatin).  Specifically, hexane extract-treated cells 
demonstrated damage to membrane integrity, resulting in a partial release of cellular 
content (indicated by arrowheads), while ethyl acetate extract-treated cells appear to have 
suffered cell wall disruption (indicated by asterisks).  The residual cell walls appeared as 
bacterial “ghosts”, with a complete absence of cytoplasmic contents, indicating cellular 
rupture.  Interestingly, these ethyl acetate extract-treated cells also demonstrated cellular 
aggregation, or possible fusing of the cells.  
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Figure 92:  TEM image of untreated Staphylococcus aureus 
 
 
 
 
 
 
 
Figure 93:  TEM image of water extract-treated Staphylococcus aureus 
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Figure 94:  TEM image of hexane extract-treated Staphylococcus aureus 
 
 
 
 
 
 
 
 
 
Figure 95:  TEM image of ethyl acetate extract-treated Staphylococcus aureus 
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GC-MS Analysis  
Each of the three extracts was submitted for gas chromatography-mass 
spectrometry analysis to determine chemical composition.  DMSO served as a control.  
20 µl of each sample was mixed with 50 µl methanol and 50 µl dichloromethane.  
Sample injection and gas chromatography were performed using an Agilent 6890 gas 
chromatograph equipped with an autosampler and an HP-5MS UI capillary column (30m, 
0.250 mm, 0.25 µm).  5 µl of each sample was injected at an injection temperature of 
320°C, using an injection mode with a split 1:10 ratio.  Helium served as the carrier gas 
at a constant rate flow of 0.9 ml/min.  The oven temperature was held at 60°C for 1 min, 
then increased to 320°C at a rate of 5°C, and held at this final temperature for 4 min.   An 
Agilent 5973 single-quadrupole mass spectrometer was used for detection using electron 
impact ionization operating in positive mode, operating under full scan mode (50-450 Da, 
1 Hz) with a solvent delay of 7 min.   
A total of 60 peaks were identified in the hexane extract sample (figure 96), 93 in 
the ethyl acetate extract sample (figure 97), and 87 in the water extract sample (figure 
98).  Spectral peaks were identified based using the NIST 1998 data library.   
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Figure 96:  GC-MS spectral results for Artemisia tridentata hexane extract 
 
 
 
 
 
Figure 97:  GC-MS spectral results for Artemisia tridentata ethyl acetate extract 
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Figure 98:  GC-MS spectral results for Artemisia tridentata water extract 
 
Among the three extracts, compounds identified with a probability value of at 
least 50 % and a peak area of at least 1 % were tabulated and compared.  43 compounds 
in the hexane extract analysis met these criteria (table 6).  Of these, seven had peak areas 
of at least 5 %.  Three of these seven are tentative identifications of the peak detected at 
the retention time of 11.04 minutes, with a peak area of 24.93 % and probable 
identification values of at least 90%.  These three are stereoisomer variations of the first 
listed compound, a terpene commonly known as “camphor.”  The next two compounds, 
with a retention time of 34.12 minutes, a peak area of 13.35 %, and also with probable 
identification values of at least 90 %, are again stereoisomers of the same compound, a 
sesquiterpene lactone with the molecular formula C15H18O3, commonly referred to as 
“achillin” or “azuleno.”  The final two compounds are again possible identifications of 
the same peak, with a retention time 10.81 minutes and a peak area of 8.49 %, tentatively 
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labeled as either “exo-2-bromonoborane,” or “Bicyclo[2.2.1]heptane, 2-(2-propenyl)-,“ 
the latter of which is also known as “2-(2-Methyl-1-propenyl)-bicyclo[2.2.1]heptane.”  
However, these two compounds have probable identification values of only 50 and 59 %, 
respectively. 
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Table 6:  Summary of GC-MS results from hexane extract analysis 
 
Peak 
Number
Retention 
Time
Area Library/ID CAS#
Probable 
Identification
4 11.04 24.93 Camphor 000076-22-2 90
4 11.04 24.93 Bicyclo[2.2.1]heptan-2-one, 1,7,7- 000464-48-2 97
4 11.04 24.93 Bicyclo[2.2.1]heptan-2-one, 1,7,7- 000464-49-3 96
44 34.12 13.35 Azuleno[4,5-b]furan-2,7-dione, 3,3  005956-04-7 91
44 34.12 13.35  Achillin         071616-00-7 90
3 10.81 8.49 exo-2-Bromonorbornane 002534-77-2 50
3 10.81 8.49 Bicyclo[2.2.1]heptane, 2-(2-propen 002633-80-9 59
37 31.40 4.68 Unidentified NA NA
56 51.40 3.30 .alpha.-Amyrin  000638-95-9 91
56 51.40 3.30  .beta.-Amyrin 000559-70-6 90
56 51.40 3.30  .beta.-Amyrin trimethylsilyl ether 001721-67-1 56
41 33.26 2.79 9,12-Octadecadienoic acid (Z,Z)- 000060-33-3 99
41 33.26 2.79 9,12-Octadecadienoic acid, methyl 002462-85-3 76
41 33.26 2.79 2-Chloroethyl linoleate 025525-76-2 87
34 30.03 2.74 Pentadecanoic acid  001002-84-2 76
34 30.03 2.74 n-Hexadecanoic acid 000057-10-3 89
34 30.03 2.74 Tridecanoic acid 000638-53-9 78
19 19.67 2.70  Benzene, 1-(1,5-dimethyl-4-hexenyl 000644-30-4 99
19 19.67 2.70 6-(p-Tolyl)-2-methyl-2-heptenol 039599-18-3 59
31 28.52 2.53 3,5-Di-tert-butylbenzoic acid  016225-26-6 59
1 7.88 2.33 Eucalyptol 000470-82-6 95
1 7.88 2.33 Trifluoroacetyl-.alpha.-terpineol 1000058-17-6 62
53 50.40 2.06  .beta.-Sitosterol   000083-46-5 50
53 50.40 2.06   .gamma.-Sitosterol   000083-47-6 99
53 50.40 2.06 Stigmasterol, 22,23-dihydro- 1000214-20-7 93
22 22.14 1.85 Caryophyllene oxide 001139-30-6 81
22 22.14 1.85 Caryophyllene oxide 1000156-32-9 94
42 33.36 1.81 9,12,15-Octadecatrien-1-ol, (Z,Z,Z  000506-44-5 83
42 33.36 1.81 9,12,15-Octadecatrienoic acid, met 000301-00-8 74
42 33.36 1.81 Bicyclo[10.1.0]tridec-1-ene 054766-91-5 53
5 11.19 1.52 Unidentified NA NA
59 52.52 1.40 .beta.-Amyrin 000559-70-6 53
59 52.52 1.40  .alpha.-Amyrin 000638-95-9 83
36 30.76 1.39 Naphtho[1,2-b]furan-2,8(3H,4H)-dio 013902-54-0 59
7 13.43 1.20 exo-2-Bromonorbornane 002534-77-2 59
7 13.43 1.20 Cyclohexene, 3-methyl-6-(1-methyle 005256-65-5 64
7 13.43 1.20 2-Butanone, 4-cyclopentylidene- 051004-21-8 64
11 14.32 1.19 Cyclobutane, 1,2-diethenyl-3,4-dim 1000034-00-1 59
16 18.15 1.04 Caryophyllene 000087-44-5 91
16 18.15 1.04 Bicyclo[7.2.0]undec-4-ene, 4,11,11 000118-65-0 76
55 50.83 1.04  Olean-12-ene 000471-68-1 72
55 50.83 1.04  Pyrrolo[2,3-b]indole, 1,2,3,3a,8,8 046479-70-3 72
16 18.15 1.04 Bicyclo[5.2.0]nonane, 2-methylene- 1000159-38-9 93
Hexane Extract GC-MS Results
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14 compounds met these criteria (probability value of at least 50 % and a peak 
area of at least 1 %) in the results for the ethyl acetate extract analysis (table 7).  In this 
case however, only four represented compounds with peak areas of at least 5 %.  The first 
two, with a retention time of 34.27 minutes, peak area of 43.13 %, and probable 
identification values of at least 90 %, again represent the sesquiterpene lactone known as 
“achillin” or “azuleno.”  The third compound, with a retention time of 49.73 minutes, 
peak area of 7.93 %, and a probable identification value of 89%, was identified as a 
tricyclic compound commonly referred to as “jaceidin.”  The fourth compound, with a 
retention time of 31.41 minutes and a peak area of 7.14 %, was unidentified.  Further 
analysis with the NIST 2008 data library failed to identify this peak with a probable 
identification value over 50 %. 
 
 
 
Table 7:  Summary of GC-MS results from ethyl acetate extract analysis 
 
 
 
Peak 
Number
Retention 
Time
Area Library/ID CAS#
Probable 
Identification
70 34.27 43.13 Azuleno[4,5-b]furan-2,7-dione, 3,3 005956-04-7 91
70 34.27 43.13 Achillin 071616-00-7 90
89 49.73 7.93 4H-1-Benzopyran-4-one, 5,7-dihydro 010173-01-0 89
62 31.41 7.14 Unidentified NA NA
6 10.95 4.36 Bicyclo[2.2.1]heptan-2-one, 1,7,7- 000464-49-3 95
6 10.95 4.36 Camphor 000076-22-2 94
6 10.95 4.36  Bicyclo[2.2.1]heptan-2-one, 1,7,7- 000464-48-2 97
14 13.49 3.29 1H-Indene, octahydro-5-methyl- 019744-64-0 50
73 35.58 2.24 Unidentified NA NA
72 34.82 1.57 Azuleno[4,5-b]furan-2,7-dione, 3,3 005956-04-7 96
72 34.82 1.57 Achillin 071616-00-7 98
74 35.89 1.40 Unidentified NA NA
60 30.76 1.27 Unidentified NA NA
35 19.04 1.07 Unidentified NA NA
Ethyl Acetate Extract GC-MS Results
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33 compounds in the results for the water extract analysis had probable 
identification values of at least 50 % and peak areas of at least 1% (table 8).  However, 
only two had peak areas of greater than 5 %.  The first, with a retention time of 34.02 
minutes, a peak area of 15.51 %, and a probable identification value of 94 %, was once 
again the sesquiterpene lactone “azuleno.”  The second, with a retention time of 23.54 
minutes and a peak area of 6.08 %, was unidentified.  Further analysis with the NIST 
2008 data library failed to identify this peak with probable identification value over 50 %. 
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Table 8:  Summary of GC-MS results from water extract analysis  
  
Peak #
Retention 
Time
Area Library/ID CAS#
Probable 
Identification
67 34.02 15.51 Azuleno[4,5-b]furan-2,7-dione, 3,3  005956-04-7 94
45 23.54 6.08 Unidentified NA NA
65 32.85 4.24 Neo-Inositol 000488-54-0 50
64 32.58 4.00 Allo-Inositol 000643-10-7 64
64 32.58 4.00 Neo-Inositol 000488-54-0 72
61 31.34 3.56 Unidentified NA NA
78 38.57 3.11 Unidentified NA NA
86 46.59 2.95 Unidentified NA NA
33 18.77 2.94 Unidentified NA NA
38 20.43 2.60 Unidentified NA NA
28 17.22 2.34 Unidentified NA NA
15 13.49 2.01 2,2-Dimethyl-1-(2-methylene-cycloh 1000187-17-4 59
15 13.49 2.01 2,5,5-Trimethyl-cyclohex-3-enone 1000193-78-3 53
15 13.49 2.01 1,3-Pentadiene, 2,4-dimethyl-  001000-86-8 50
46 23.82 1.89 Unidentified NA NA
82 40.32 1.76 Thieno[2,3-b]thiophene, 2-ethyl-  005912-01-6 52
29 17.35 1.68 Unidentified NA NA
52 26.21 1.67 Unidentified NA NA
35 18.99 1.64 3,6-Octadien-1-ol, 3,7-dimethyl-, 005944-20-7 83
72 35.46 1.62 Unidentified NA NA
54 28.71 1.37 Unidentified NA NA
63 31.94 1.37  Allo-Inositol 000643-10-7 50
63 31.94 1.37 Scyllo-Inositol 000488-59-5 50
63 31.94 1.37 Inositol 006917-35-7 50
79 39.20 1.21 Unidentified NA NA
73 35.80 1.20 Unidentified NA NA
75 37.65 1.12 Unidentified NA NA
87 49.63 1.08 4H-1-Benzopyran-4-one, 5,7-dihydro  010173-01-0 83
49 24.68 1.03 Phenol, 2,6-dimethoxy-4-(2-propeny 006627-88-9 91
49 24.68 1.03  2-Propenoic acid, 3-(4-hydroxy-3-m 001135-24-6 89
51 25.52 1.03 Phenol, 4-(3-hydroxy-1-propenyl)-2  000458-35-5 89
51 25.52 1.03 (+)-s-2-Phenethanamine, 1-methyl-N 1000127-89-6 50
51 25.52 1.03 2-Butanone, 3-(phenylthio)- 013023-53-5 64
Water Extract GC-MS Results
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Column Chromatography 
Following analysis of the GC-MS results, newly created hexane extracts were 
subjected to solid-phase extraction to potentially identify the compound(s) responsible for 
growth inhibition of Staphylococcus aureus.  Two hexane extracts were created by direct 
treatment of the plant material with this solvent:  The first extract was created by the 
boiling of 5.0067 g of Artemisia tridentata plant material, dried and ground using a 
mortar and pestle, in 50 ml hexane for approximately 45 minutes using a reflux 
condenser.  After treatment, the supernatant was decanted and filtered through cotton.  50 
ml fresh hexane was added to the plant material, and the process repeated.  The pooled 
filtrates were subjected to an additional filtration using Whatman #1 paper to remove still 
visible particulate matter.  The second extract was created by adding 5.0076 g more of 
dried and ground plant material to the original material, and repeating a similar process.  
Solvent was removed from both samples using a rotary evaporator and desiccation under 
vacuum.  Each resulting extract was suspended in 5 ml DMSO, filtered first through a 0.2 
µm syringe filter, and then through Whatman #1 filter paper to remove still visible 
particulate matter.   
Column chromatography of the extracts was based on the method of Mojarrab et 
al.
113
.  3 ml of a solution composed of 95% methanol and 5% DMSO was passed through 
a Sep-Pak C18 cartridge (Waters) to pre-treat the column.  This process was repeated 
four times.  The first hexane extract was then passed through the column, after which the 
column was washed using the methanol/DMSO solution in four applications of 3 ml 
each. The column was then treated successively with 3 ml volumes of acetonitrile/water 
solutions to create fractioned samples of the hexane extract.  The first solution contained 
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10% acetonitrile and 90% water, with each following solution containing a 10% 
incremental increase in acetonitrile, thus the last solution consisted only of this solvent.  
The flow-through from each of these ten solutions was collected in separate vials.  The 
process was then repeated with a new column and the second hexane extract, and the 
flow-through from each acetonitrile/water solution treatment combined with the 
corresponding collected flow-through from the first extract. 
Solvent was removed from the column fractions using rotary evaporation.  Based 
on the results of a previous experiment (data not shown), the 10% acetonitrile and 100% 
acetonitrile fractions were subjected to GC-MS analysis.  10 µl of the 10% acetonitrile 
sample, which had an oily appearance, was re-suspended in 100 µl of a 50% 
dichloromethane/methanol solution.  Alternatively, as the 100 % acetonitrile fraction 
appeared as a non-motile residue in only a trace amount, 300 µl of 
dichloromethane/methanol solution was used to wash the vial containing this sample.  5 
µl of each resulting solution was injected (split mode, 1:10 ratio) into an Agilent 6890 
Gas Chromatograph equipped with an Agilent 5973 single quadrupole mass 
spectrometer.  The 10 % acetonitrile fraction sample yielded 14 peaks (figure 99), while 
the 100 % acetonitrile sample yielded 34 (figure 100).  Compounds were identified using 
the NIST 1998 data library.   
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Figure 99:  GC-MS results for 10 % acetonitrile column fraction of hexane extract 
 
 
 
 
 
Figure 100:  GC-MS results for 100 % acetonitrile column fraction of hexane extract 
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After rotary evaporator removal of the dichlormethane/methanol solvent from the 
100% acetonitrile fraction, all ten pooled column fractionation samples were assayed for 
antibacterial effects versus Staphylococcus aureus.  As most of the samples yielded only 
small amounts of visible residue after acetonitrile/water removal, each vial was washed 
with 500 µl LB, and this sample-containing media added in 100 µl aliquots in triplicate to 
the wells of a 96-well plate.  An overnight culture of Staphylococcus aureus was 
incubated at approximately 37°C and 225 rpm for about 16 hours, and diluted to an 
OD600 reading of 1.020 before the addition of 2 µl culture to the appropriate wells.  
Controls (100 µl each) included untreated LB (sterility), tetracycline in LB at 25 µg/ml 
(positive), and untreated Staphylococcus aureus (negative), with each performed in 
triplicate.  The plate was incubated at 37°C and 125 rpm, with measurements taken 
immediately prior to incubation, and at 1-hour intervals for 6 hours.  As can be seen in 
figure 101, only the 10% acetonitrile fraction appeared to inhibit bacterial growth over 
this period. 
 
 
 
Figure 101:  Antibacterial assay of hexane extract column fractions 
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Compounds identified in the 10% acetonitrile fraction with a probability value of 
at least 50 % and a peak area of at least 1 %, were tabulated.  Seven compounds met 
these criteria (table 9).  Of these, only the sesquiterpene lactone “achillin” or “azuleno,” 
had a probable identification value of greater than 90 %, and a peak of greater than 5 %. 
 
 
Table 9:  Summary of GC-MS results from 10 % acetonitrile column fraction analysis 
 
Peak 
Number
Retention 
Time
Area Library/ID CAS#
Probable 
Identification
2 13.52 2.56 1,3-Pentadiene, 2,4-dimethyl- 001000-86-8 59
2 13.52 2.56 2,5,5-Trimethyl-cyclohex-3-enone 1000193-78-3 53
11 23.71 1.31 Methyl jasmonate 001211-29-6 93
11 23.71 1.31 Cyclopentaneacetic acid, 3-oxo-2-( 042536-97-0 93
11 23.71 1.31  (3-Oxo-2-pent-2-enylcyclopentyl)ac 1000211-13-7 95
14 34.15 56.36 Achillin  071616-00-7 99
14 34.15 56.36  Azuleno[4,5-b]furan-2,7-dione, 3,3 005956-04-7 96
Hexane Extract GC-MS Results
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IV. DISCUSSION 
Evaluation of Results 
 The results of the antibacterial assays using the ethyl acetate, hexane and water 
extracts derived from Artemisia tridentata plant material strongly indicate the presence of 
an antibacterial compound(s) capable of selective growth inhibition of Staphylococcus 
aureus.  Given the initial bacterial inoculum levels and experimental conditions used in 
these assays, all three extracts significantly negatively impacted the growth of this 
bacterial species over a period of 6 hours in comparison to untreated controls.  The ethyl 
acetate extract displayed statistically significant antibacterial effects at the lowest 
concentration (62.5 µg/ml), followed by the hexane extract (125 µg/ml), and finally the 
water extract (250 µg/ml), which demonstrated the least amount of growth inhibition.  
Interestingly however, at a concentration of 500 µg/ml, it was the hexane extract-treated 
growth curves which most closely resembled those of the positive control. 
Further, applications of these extracts in combination with the antibiotics G418 
sulfate, amikacin and ampicillin enhanced the antibacterial efficacy of all three drugs.  
Statistically significant improvement of growth inhibition was routinely observed when 
these combinatorial effects were compared to those of the antibiotics alone.  At the 
antibiotic concentration of 1.25 µg/ml for example, G418 sulfate and amikacin 
performances were enhanced by ethyl acetate extract concentrations as low as 62.5 
µg/ml, while ampicillin was enhanced by a hexane extract concentration as low as 125 µl.  
The failure of the ethyl acetate extract to also demonstrate enhancement of ampicillin 
effects at the lowest concentration among the extracts is explicable upon examination of 
the growth curve graphs.  It can be observed that in the hexane extract/ampicillin 
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combination assays that the untreated controls grew to higher levels in comparison to the 
ethyl acetate/ampicillin combination assays, and that the final readings for combinations 
of extracts with 1.25 µg/ml ampicillin were actually higher in the latter.  Thus, some of 
the inhibitory effects of the hexane extract/ampicillin combinations were statistically 
significant due to the greater growth of the untreated control in those assays, despite 
growth inhibition at these combined concentrations being greater in the ethyl 
acetate/ampicillin assays. 
Over 12 hours, the extracts continued to enhance the antibacterial efficacy of 
these antibiotics.  Combinations of the ethyl acetate and hexane extracts, though at 
concentrations of 500 µg/ml, with either G418 sulfate or amikacin, strongly inhibited 
Staphylococcus aureus, with growth curves mimicking those of the positive control.  
Combined effects with ampicillin were less dramatic, which is consistent with the results 
of the 6-hour assays.  However, the hexane extract clearly demonstrated the greatest 
combined effects with ampicillin in the 12-hour assays.   
The assays assessing the performance of the extracts in combination did not 
reveal any significant enhancement of antibacterial efficacy which might suggest the 
presence of additive or synergistic compounds.  However, the values for the hexane/ethyl 
acetate extract combinations showed enough reduction of growth inhibition to suggest 
possible interference or antagonism between the two.  Yet it is also possible that these 
elevated growth levels were due to nutrient enrichment of the media by the extracts, 
which resulted in more rapid bacterial growth.  Though not discussed in the reviewed 
literature, it is important to consider that along with potential antibacterial compounds, 
chemical extraction of plant material also potentially withdraws many chemicals which 
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can be used by bacteria as energy sources, thereby enriching the level and variety of 
nutrients in media when added in antibacterial assays.  In many instances in this study, 
lower concentrations of extracts alone or in combination with antibiotics were observed 
to exhibit growth curves surpassing those of the untreated controls.  This can complicate 
the assessment of an extract’s antibacterial efficacy, as its true potency may be 
diminished by the promotion of bacterial growth due to these additional compounds.  In 
any case, as there was still significant growth inhibition by the hexane/ethyl acetate 
extract combination in comparison to the untreated control at the highest concentrations 
tested, antagonist effects could be considered moderate. 
 The antibacterial efficacy of each extract was lessened when tested against the 
ampicillin resistant strain BAA-44, with significant growth inhibition seen only at the 
highest tested concentration (500 µg/ml) of the ethyl acetate and hexane extracts.  As 
ampicillin resistance in this strain is the result of the action of a β-lactamase, this lessened 
efficacy is difficult to explain.  If this enzyme were to react in some manner with the 
antibacterial compound(s) in the extracts, a similar lessening of the combined efficacy of 
the extracts with ampicillin would be expected.  However, both the ethyl acetate and 
hexane extracts significantly improved the growth inhibition of all ampicillin 
concentrations tested in comparison to their performances alone, with the growth curves 
of hexane extract/ampicillin combinations mimicking those of the positive control.  It is 
possible that the antibacterial efficacy of the extracts, when applied alone, was masked by 
the slow growth of the untreated controls in these assays.   
 Under the experimental conditions tested, none of the extracts displayed any 
inhibitory effects on Staphylococcus aureus biofilm formation.  The 10-hour incubation 
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period allowed for biofilm formation in these assays exceeded the antibacterial assays by 
4 hours, so this may have diminished extract effects to some extent.  Still, the 
quantification of crystal violet binding indicated higher biofilm formation in the extract-
treated samples.  It is again possible that the extracts enriched the test media, and that this 
resulted in more rapid bacterial growth after the antibacterial capacity of the extracts was 
overwhelmed.  Alternatively, as the plates were incubated without rotation, biofilm 
formation early in the assay may have protected the cells within from the extracts, 
rendering them ineffective. 
 The extracts, alone or in combination with antibiotics, also had no effects in the 
treatment of static biofilms.  The length of sample treatment in these assays was 12 hours.  
Given the results of extract/antibiotic combinations from the earlier 12-hour antibacterial 
assays, and the use of 1 mg concentrations of antibiotics in the treatment of the static 
biofilms, some reduction of the biofilms might have been expected.  The lack of positive 
results is most likely attributable to the resistive capabilities of the biofilm to the extracts 
and antibiotics.  However, if the antibacterial effects of the extracts are bacteriostatic as 
opposed to bactericidal in nature, this could also explain their ineffectiveness versus a 
static biofilm.     
 In the serial dilution and plating of extract-treated Staphylococcus aureus 
samples, the overnight cultures, after adjustment to an OD600 reading approximating 
1.000, yielded a colony count average of 1.45 x 10
8
 cells/ml.  Given the approximate 2 µl 
culture:100 µl media ratio that was used in both these assays and the earlier antibacterial 
assays, this number would translate to bacterial inoculum concentrations of about 2.9 x 
10
6
 cells/ml ([1.45 x 10
8
 cell/ml x 0.002]/ 0.1 ml), considerably less than the 1.52-1.68 x 
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10
7
 cells/ml estimated for the earlier antibacterial assays using the standard Escherichia 
coli value for an OD600 reading of 1.000.  However, these experimental numbers are 
estimates, based on only three trials, and neglecting to take into consideration the optical 
alignment of the spectrophotometer
114
. 
 The average colony count of 3.79 x 10
6
 cells/ml for the untreated control sampled 
after 25 minutes of incubation is reasonably representative of the calculated inoculum 
level, given that the experiment was performed only three times.  The comparatively low 
average colony count of 1.73 x 10
5
 cells/ml for the tetracycline-treated samples could 
either be due to a bacteriostatic effect on cells in the inoculums which were already in the 
process of dividing, or to a bactericidal effect of the aminoglycoside at this concentration 
to cell ratio
115
.  The average colony count for the 2-hour untreated sample (2.8 x 10
7
 
cells/ml) indicates 3 to 4 rounds of division by the cells in the initial inoculum, which 
reinforces an estimated doubling time of around 35 minutes under these experimental 
conditions.  Therefore, as the colony counts for the extract-treated samples closely 
approximated that of the untreated control after 25 minutes, these results are indicative of 
a bacteriostatic, as opposed to bactericidal, mechanism of action, which is in agreement 
with the literature.   
 The toxicity assay results imply that at the concentrations which demonstrated 
significant growth inhibition in the earlier antibacterial assays, these extracts are 
moderately to very lethal against MDA-MB-231 cells.  They could therefore be 
hazardous to human health if taken internally, which would also be in agreement with the 
literature.  However, it is possible that the antibiotic compound(s) in the extracts are not 
responsible for this toxicity, and that the use of an alternative solvent in the creation of an 
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extract, or the physical isolation of the antibiotic compound(s), might result in safer 
products.  Also, these results do not necessarily discount the usefulness of extracts or 
compounds derived from Artemisia tridentata in external applications, such as those also 
described in the literature.    
The GC-MS results for the three extracts indicate achillin, a sesquiterpene 
lactone, as the most likely candidate responsible for these effects, as this was the only 
compound identified as present in all three tested samples under the chromatographic and 
mass spectral analytical conditions employed.  The identification of this compound in the 
hexane extract column fraction exhibiting antibacterial activity further supports this 
conclusion.  However, it should be noted that the antibacterial assay was performed by 
adding media directly to the samples without regard to concentration, due to the 
fractionation resulting in very limited individual volumes.  The 10% acetonitrile sample 
demonstrating Staphylococcus aureus growth inhibition consisted of perhaps as much as 
20-30 µl, a volume larger than that typically added to achieve the highest concentration 
tested in the extract assays (500 µg/ml).  Also, as the concentration of individual 
compounds was likely changed as a result of the column fractionation process, there 
exists the possibility, however unlikely, that another compound(s) present in this fraction 
was responsible for this antibacterial effect, and that this effect was only exerted due to 
the use of an excessive concentration of this compound(s).   It should also be noted that 
GC-MS analysis of the three extract samples revealed additional compounds unique to 
each extract which may possess antibacterial properties.  Therefore, it is possible that 
achillin is not the only antibacterial compound present in Artemisia tridentata, and that its 
natural bacterial defense mechanisms consist of the use of more than one compound. 
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 Nevertheless, the crediting of the antibacterial properties of this plant to the 
presence of a sesquiterpene lactone is in line with existing literature on the subject.  
Sesquiterpene lactones are lipophilic fifteen-carbon compounds believed to be formed 
through the condensation of three isoprene units, followed by cyclization and oxidative 
transformation to cis or trans-fused lactones
101
.  These compounds are typically found in 
glandular trichomes and secretory canals of plants, and are believed to be one of the main 
mechanisms of plant microbial defense, disrupting the bacterial cell membrane through 
interaction of the constituent polar groups with the phospholipid membrane
101
.  Indeed, it 
has been suggested that this class of compound is perhaps the largest of those to be found 
to exist as secondary metabolites in plants, with over 5,000 structures identified to 
date
101
.   
While assays investigating the potential role of pH or DNA-damaging effects 
failed to demonstrate positive results, the ethidium bromide assay and electron 
microscopy results both support the idea of a mechanism of action involving bacterial 
membrane disruption.  The ethidium bromide assay results for example, demonstrated 
enhanced binding to cellular DNA in the presence of the extracts, which is indicative of 
increased membrane permeability, while the transmission electron microscopy results 
indicated cellular rupture in the ethyl acetate and hexane extract-treated samples.  
However, these results alone cannot completely discount the possibility of autocidal 
activity resulting from extract toxicity towards Staphylococcus aureus.   
Experimental Shortcomings 
 As noted in the introductory literature review, a completely exhaustive 
examination of the antibacterial properties of a plant would likely require an enormous 
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amount of trial and error using a variety of sampling, extraction, testing and identification 
methods.  Therefore, it is important to acknowledge the limitations of this particular 
study.  First, as reported, the Artemisia tridentata plant material obtained was collected 
from one location during the month of November.  It is possible that sample collections 
from other locations or from the same location at a different time(s) would have resulted 
in variability in the level of achillin or other compounds contributing to the antibacterial 
activity of the plant extracts.  For example, it has been reported that autumn is the time of 
year when the essential oil content of sagebrush species is at its peak
99
.  However, it has 
also been reported that this species remains photosynthetically active even during periods 
of cold, thus these fluctuations may be minimal
116
 if metabolic energy availability is 
consistent throughout the year.  Second, the extracts tested were made predominantly 
from leaf material, as limited amounts of stems or flowers, and no roots were obtained.  
The chemical composition and antibacterial activity of extracts created from different 
parts of this plant may vary, perhaps significantly if the roots possess excretory secretory 
canals containing achillin or other antibacterial compounds.   
 Additionally, in the creation of the extracts used for the bulk of the antibacterial 
testing, the original solvent applied to the plant material was methanol, with subsequent 
extracts created by fractionation of the resulting solution.  It is very likely that methanol 
failed to extract all constituent compounds in the treated plant material.  Had time and the 
availability of plant material allowed, the treatment of individual plant samples with 
various solvents on an individual basis, or the sequential treatment of a single sample 
with these solvents, may have potentially resulted in extracts with greater and/or wider-
ranging antibacterial properties.  Further, the antibacterial testing included only four 
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bacterial species, and only three antibiotics were screened for additive or synergistic 
effects in combination with the plant extracts.  A more expansive screening of both may 
have revealed greater potential applicability of the extracts.  Finally, attempts to 
determine the chemical composition of the extracts were potentially limited by the 
approaches taken in the chromatographic and spectral analyses.  For example, it is 
possible that the chromatographic settings used, the molecular mass cutoff values of the 
mass spectral analyses, or the use of outdated reference databases resulted in the 
misidentification or failed identification of a relevant compound(s) in the samples. 
Future Experiments 
 We were unable to obtain purified achillin through commercial sources.  The 
physical isolation and purification of achillin from Artemisia tridentata plant material 
would allow for a more accurate assessment of its antibacterial potency and mechanism 
of action against Staphylococcus aureus, as well as perhaps some other bacterial species 
with similar cell membrane compositions.  Such testing would also reveal whether these 
effects, exhibited by the chemical extracts in the experiments described herein, are the 
result of this compound alone, or if it is possible that one or more of the other chemicals 
identified by GC-MS analysis as present in these extracts contributed to bacterial growth 
inhibition in some manner.  Further, the chemical structure of achillin suggests 16 
possible stereo-configurations.  While the bioactivity of sesquiterpene lactones has been 
reported as attributable to the presence of the α-methylene-γ-lactone group101, isolation 
and purification would allow for structural determination of the specific stereoisomer 
produced by this plant species, and perhaps allow for the design of experiments to test 
whether this configuration is relevant to this compound’s antibacterial activity. 
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 It would also be interesting to modify and repeat the antibacterial assays testing 
the methanol extracts of the fifteen plant species screened prior to Artemisia tridentata. 
The demonstration of any “meaningful” antibacterial activity possessed by the extracts 
created from this plant was only observed after reducing the bacterial inoculum level in 
the assays performed.  Further, these effects were initially detected using a working 
concentration as high as 1000 µg/ml.  This illustrates the difficulties in detecting 
antibacterial properties in plant investigations, as these properties would likely have been 
missed without these experimental modifications.  In an antibacterial assay, the working 
concentration of the tested chemical and the inoculum level are interdependent, with 
either value relatively meaningless without consideration of the other.  Therefore, a better 
experimental approach in the future, for example, may be to initially test extracts using a 
pre-determined, set value for working concentration, doing so against a gradient of 
bacterial inoculum levels.  Such an assay design might allow for a faster and more 
practical assessment of an extract’s potency.  
Finally, with regards to further experiments involving Artemisia tridentata, as 
well as other plants, it would be beneficial to expand the number of pathogenic bacterial 
species assayed, as the antibacterial effects of some plants may be exerted against a very 
limited number of bacteria, and including a greater number of test species may help 
detect them.  Also, as described in the literature review, comparisons of results from 
testing bacterial species with different phenotypes can be useful in discerning 
antibacterial mechanisms of action.  Similarly, when investigating combined applications 
with antibiotics, a greater number of drugs representing different classes should be  
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included, which will improve the odds of discovering additive or synergistic effects 
between these and the plant extracts.  
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